Advanced search
Publication Cover
Critical Reviews in Toxicology Volume 44, 2014 - Issue sup4: Special Issue Title: Systematic Review of Potential Health Risks Posed by Pharmaceutical, Occupational and Consumer Exposures to Metallic and Nanoscale Aluminum, Aluminum Oxide, Aluminum Hydroxide and its Soluble Salts
Submit an article Journal homepage
3,639
Views
261
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts

Calvin C. WillhiteRisk Sciences International, Ottawa, ON, Canada;McLaughlin Centre for Population Health Risk Assessment, Ottawa, ON, CanadaCorrespondence[email protected]
,
Nataliya A. KaryakinaRisk Sciences International, Ottawa, ON, Canada
,
Robert A. YokelPharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA
,
Nagarajkumar YenugadhatiMcLaughlin Centre for Population Health Risk Assessment, Ottawa, ON, Canada
,
Thomas M. WisniewskiDepartments of Neurology, Psychiatry and Pathology, New York University School of Medicine, New York City, New York, USA
,
Ian M.F. ArnoldOccupational Health Program, Faculty of Medicine, McGill University, Montreal, QC, Canada
,
Franco MomoliOttawa Hospital Research Institute, Ottawa, ON, Canada;Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada;Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada
&
Daniel KrewskiRisk Sciences International, Ottawa, ON, Canada;McLaughlin Centre for Population Health Risk Assessment, Ottawa, ON, Canada;Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
 show all
Pages 1-80 | Received 23 Dec 2013, Accepted 10 Jun 2014, Published online: 18 Sep 2014

References

  • Abd El-Rahman M, el-Khadragy MF, Abd-el HH, Gab-Allah DM. (2011). Effect of some cement components on ion contents in different brain areas of adult male albino mice. J Hazard Mate, 186, 1527–40.
  • Abdel-Aal RA, Assi AA, Kostandy BB. (2011a). Rivastigmine reverses aluminum-induced behavioral changes in rats. Eur J Pharmacol, 659, 169–76.
  • Abdel-Aal RA, Assi AA, Kostandy BB. (2011b). Memantine prevents aluminum-induced cognitive deficit in rats. Behav Brain Res, 225, 31–8.
  • Abd-Elghaffar SKH, El Sokkary GH, Sharkawy AA. (2007). Aluminum-induced neurotoxicity and oxidative damage in rabbits: Protective effect of melatonin. Biogenic Amines, 21, 225–40.
  • Abubakar MG, Taylor A, Ferns GA. (2003). Aluminium administration is associated with enhanced hepatic oxidant stress that may be offset by dietary vitamin E in the rat. Int J Exp Pathol, 84, 49–54.
  • Abu-Taweel GM, Ajarem JS, Ahmad M. (2011a). Neurobehavioral toxic effects of perinatal oral exposure to aluminum on the developmental motor reflexes, learning, memory and brain neurotransmitters of mice offspring. Pharmacol Biochem Behav, 101, 49–56.
  • Abu-Taweel GM, Ajarem JS, Ebaid H. (2011b). Aluminum-induced testosterone decrease results in physiological and behavioral changes in male mice. Afr J Biotechnol, 10, 201–8.
  • ACGIH (American Conference of Governmental Industrial Hygienists). (2008). TLVs® and BEIs® Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. Cincinnati: ACGIH.
  • ACGIH (American Conference of Governmental Industrial Hygienists). (1991). Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th edition. Cincinnati: ACGIH. pp. 46–7.
  • Adamcakova-Dodd A, Stebounova LV, O’Shaughnessy PT, Kim JS, Grassian VH, Thorne PS. (2012). Murine pulmonary responses after subchronic exposure to aluminum oxide-based nanowhiskers. Part Fibre Toxicol, 9, 22.
  • Afriyie-Gyawu E, Ankrah NA, Heubner HJ, Ofosuhene M, Kumi J, Johnson NM, et al. (2008). NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes. Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 25, 76–87.
  • Afriyie-Gyawu E, Mackie J, Dash B, Wiles M, Taylor J, Huebner H, et al. (2005). Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit Contam, 22, 259–69.
  • AFSSAPS (Agence Francaise de Sécurité des Produits de Santé). (2011). Ěvaluation du Risque lié á l'utilisation de l’Aluminium dans les Produits Cosmétiques. Saint-Denis, France: AFSSAPS. pp. 1–44. Available at: www.afssaps.fr http://opac.invs.sante.fr./index.php?lul = notice_display&id = 5478 (denière consultation le 28/01/2011) Accessed on 10 June 2013.
  • Agah H, Leermakers M, Elskens M, Rez Fatemi SM, Baeyens W. (2009). Accumulation of trace metals in the muscle and liver tissue of five fish species from the Persian Gulf. Environ Monit Assess, 157, 499–514.
  • Aghilinejad M, Javad Mousavi SA, Nouri MK, Ahmadi AB. (2012). Work-related musculoskeletal complaints among workers of Iranian aluminum industries. Arch Environ Occup Health, 67, 98–102.
  • Ahmed HH, Shousha WG, Hussien RM, Farrag ARH. (2011). Potential role of some nutraceuticals in the regression of Alzheimer's disease in an experimental animal model. Turk J Med Sci, 41, 455–66.
  • Akatsu H, Hori A, Yamamoto T, Yoshida M, Mimuro M, Hashizume Y, et al. (2011). Transition metal abnormalities in progressive dementias. Biometals, 25, 337–50.
  • Akay C, Kalman S, Dündaröz R, Sayal A, Aydin A, Ozkan Y, Gül H. (2008). Serum aluminum levels in glue-sniffer adolescent and in glue containers. Basic Clin Pharmacol Toxicol, 102, 433–6.
  • Akila R, Stollery BT, Riihimaki V. (1999). Decrements in cognitive function in metal inert gas welders exposed to aluminum. Occup Environ Med, 56, 632–9.
  • Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. (2000). Inflammation and Alzheimer's disease. Neurobiol Aging, 21, 383–421.
  • Akiyama H, Hosokawa M, Kametani F, Kondo H, Chiba M, Fukushima M, Tabira T. (2012). Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice. Neuropathol, 32, 390–7.
  • Al-Ashmawy MAM. (2011). Prevalence and public health significance of aluminum residues in milk and some dairy products. J Food Sci, 76, T73–6.
  • Albizzati A, Moré L, DiCandia D, Saccani M, Lenti C. (2012). Normal concentrations of heavy metals in autistic spectrum disorders. Minerva Pediatr, 64, 27–31.
  • Alemmari A, Miller GG, Arnold CJ, Zello GA. (2011). Parenteral aluminum induces liver injury in a newborn piglet model. J Pediatr Surg, 46, 883–7.
  • Alemmari A, Miller GG, Bertolo RF, Dinesh C, Brunton JA, Arnold CJ, Zello GA. (2012). Reduced aluminum contamination decreases parenteral nutrition associated liver injury. J Pediatr Surg, 47, 889–94.
  • Alessio L, Apostoli P, Ferioli A, Di Sipio I, Mussi I, Rigosa C, Albertini A. (1989). Behaviour of biological indicators of internal dose and some neuro-endocrine tests in aluminium workers. Med Lav, 80, 290–300.
  • Ali MA, Simin EV, Rahim C. (2008). Effect of oral aluminum chloride administration during lactation on short and long-term memory of their offspring. J Biol Sci, 8, 767–72.
  • Alleyne T, Mohan N, Joseph J, Adogwa A. (2011). Unraveling the role of metal ions and low catalytic activity of cytochrome c oxidase in Alzheimer's disease. J Mol Neurosci, 43, 284–9.
  • Altekruse EB, Chaudhary BA, Pearson MG, Morgan W.K.C. (1984). Kaolin dust concentrations and pneumoconiosis at a kaolin mine. Thorax, 39, 436–41.
  • Andreoli SP, Bergstein JM, Sherrard DJ. (1984). Aluminum intoxication from aluminum containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med, 310, 1079–84.
  • Andress DL, Maloney NA, Endres DB, Sherrard DJ. (1986). Aluminum-associated bone disease in chronic renal failure: High prevalence in a long-term dialysis population. J Bone Miner Res, 1, 391–8.
  • ANSI/AAMI (American National Standards Institute). 2004. Dialysate for hemodialysis. ANSI/AAMI RD52:2004. Arlington, Virginia: Association for the Advancement of Medical Instrumentation. pp. 53.
  • Aparecida D. (2009). Exposicao a aditivos alimentares contend aluminio como fator de Risco a saude publica non Brasil, Diretoria regional de Brasilia, Fundacao Oswaldo cruz, 2009. Brazilian Ministry of Health, General Office of Food.
  • Aremu DA, Ezomo OF, Meshitsuka S. (2011). Gene expression in primary cultured astrocytes affected by aluminum: alteration of chaperons involved in protein folding. Environ Health Prev Med, 16, 16–24.
  • Arenas MD, Malek T, Gil MT, Moledous A, Núñez C, Alvarez-Ude F. (2008). Uso de captores aluminicos en hemodiálisis en la era del agua ultrapura. [Use of aluminum-based phosphate chelation in hemodialysis in the era of ultrapure water]. Nefrología, 28, 168–73.
  • Armstrong RA. (2013). What causes Alzhiemer's disease? Folia Neuropathol, 51, 169–88.
  • Arnich N, Sirot V, Riviere G, Jean J, Noel L, Guerin T, Leblanc JC. (2012)Dietary exposure to trace elements and health risk assessment in the 2nd French total diet study. Food Chem, 50, 2432–49.
  • Arnold CJ, Miller GG, Zello GA. (2003). Parenteral nutrition-associated chloestasis in neonates: the role of aluminum. Nutr Rev, 61, 306–10.
  • ASCN/ASPEN (American Society for Clinical Nutrition Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions). (1991). Parenteral drug products containing aluminum as an ingredient or a contaminant: response to Food and Drug Administration notice of intent and request for information. J Parenter Enteral Nutr, 15, 194–8.
  • ATSDR (Agency for Toxic Substances and Disease Registry). (2008). Toxicological Profile for Aluminum. Atlanta: U.S. Department of Health and Human Services, Public Health Service. pp. 357.
  • Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, et al. (1998). Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem, 273, 2817–26.
  • Avcin S, Jazbec J, Jancar, J. (2008). Subcutaneous nodule after vaccination with an aluminium- containing vaccine. Acta Dermatovenerol Alp Panonica Adriat, 17, 182–4
  • Azik FM, Ekim M, Sakallioglu O, Aydin A. (2011). A different interaction between parathyroid hormone, calcitriol and serum aluminum in chronic kidney disease; a pilot study. Intl Urol Nephrol, 43, 467–70.
  • Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG. (2002). Food intake, water intake and drinking spout side preference of 28 mouse strains. Behav Genet, 32, 435–43.
  • Bakar C, Karaman HI, Baba A, Sengünalp F. (2010). Effect of high aluminum concentration in water resources on human health, case study: Biga Peninsula, northwest part of Turkey. Arch Environ Contam Toxicol, 58, 935–44.
  • Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BJ, van de Sluis B, et al. (2011). Clearance of p16Ink4a-positive senescent cell delays ageing-associated disorders. Nature, 479, 232–6.
  • Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Hussain SM, Grover P. (2010). In vitro mutagenicity assessment of aluminum oxide nanomaterials using the Salmonella/microsome assay. Toxicol In Vitro, 24, 1871–6.
  • Banasik A, Lankoff A, Piskulak A, Adamowska K, Lisowska H, Wojcik A. (2005). Aluminum-induced micronuclei and apoptosis in human peripheral-blood lymphocytes treated during different phases of the cell cycle. Environ Toxicol, 20, 402–6.
  • Barrow CJ, Zagorski MG. (1991). Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science, 253, 179–82.
  • Bast-Petterson R, Drablos PA, Goffeng LO, Thomassen Y, Torres CG. (1994). Neuropsychological deficit among elderly workers in aluminum production. Am J Ind Med, 25, 649–62.
  • Bast-Petterson R, Skaug V, Ellingsen D, Thomassen Y. (2000). Neurobehavioral performance in aluminum welders. Am J Ind Med, 37, 184–92.
  • BASF. (2011). Colloidal hydrated magnesium alumino-silicate. Available at: http://www.supmat.com/downloadBASF/Attapulgite%20Final%2011.15.2007.pdf [Accessed on 10 June 2013].
  • Bates D, Parkinson IMS, Ward MK, Kerr DNS. (1985). Aluminum encephalopathy. Contr Nephrol, 45, 29–41.
  • Batista-Duharte A, Lindblad EB, Oviedo-Orta E. (2011). Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett, 203, 97–105.
  • Batten GL, Lafayette GK. (undated).Aluminum oxide, soluble aluminum and coral toxicity. Available at: www.seachem.com/support/Aluminum SolubilityToxicity.pdf [Accessed on 19 May 2014].
  • Battersby R. (2007). Fact Sheet 05: Health Risk Assessment Guidance for Metals: Mutagenicity. Available at: www.metalsriskassessment.org [Accessed on 10 June 2013].
  • Baum L, Chan IH, Cheung SK, Goggins WB, Mok V, Lam L, et al. (2010). Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals, 23, 173–9.
  • Beach JR, de Klerk NH, Fritschi L, Sim MR, Musk AW, Benke G, et al. (2001). Respiratory symptoms and lung function in bauxite miners. Int Arch Occup Environ Health, 74, 489–94.
  • Beaney AM, Smeaton I. (2010). Aluminium levels in parenteral nutrition – time to change to plastic ampoules of calcium gluconate? Group L Hospital Pharmacy Practice. 15th Anniversary Congress of the European Association of Hospital Pharmacists (EAHP). 24–26 March. Nice, France. pp. 3.
  • Becaria A, Lahiri DK, Bondy SC, Chen D, Hamadeh A, Li H, et al. (2006). Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. Neuroimmunol, 176, 16–23.
  • Belaid-Nouira Y, Bakhta H, Bouaziz M, Flehi-Slim I, Haouas Z, Ben CH. (2012). Study of lipid profile and parieto-temporal lipid peroxidation in AlCl(3) mediated neurotoxicity. Modulatory effect of fenugreek seeds. Lipids Health Dis, 11, 16.
  • Bell ML, Belanger K, Ebisu K, Gent JF, Lee HJ, Koutrakis P, Leaderer BP. (2010). Prenatal exposure to fine particulate matter and birth weight: variations by particulate constituents and sources. Epidemiology, 21, 884–91.
  • Bémer D, Régnier R, Subra I, Sutter B, Lecler MT, Morele Y. (2010). Ultrafine particles emitted by flame and electric arc guns for thermal spraying of metals. Ann Occup Hyg, 54, 607–14.
  • Benford DJ, Agudo A, Baskaran C, DlNovi M, Folmer D, Leblanc J-C, Renwick AG. (2012). Aluminium-containing food additives (addendum). WHO Additives Series 65: Safety Evaluation of Certain Food Additives and Contaminants. Geneva: Food and Agriculture Organization of the United Nations/World Health Organization. Available at:http://whqlibdoc.who.int/publications/2012/9789241660655_eng.pdf [Accessed on 10 June 2013].
  • Berend K, Van Der Voet G, Boer WH. (2001). Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe. Kidney Intl, 59, 746–53.
  • Bergfors E, Björkelund C, Trollfors B. (2005). Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines. Eur J Pediatr, 164, 691–7.
  • Bergfors E, Trollfors B. (2012). Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines- prognosis and outcome after booster vaccination. Eur J Pediatr, 172, 171–7.
  • Berthon G. (2002). Aluminum speciation in relation to aluminum bioavailability, metabolism and toxicity. Coordin Chem Rev, 228, 319–41.
  • Beveridge, MG, Polcari IC, Burns JL, Adler A, Hendrickson B, Stein SL. (2011). Local vaccine site reactions and contact allergy to aluminum. Pediatr Dermatol, 29, 68–72.
  • Bhadauria M. (2012). Combined treatment of HEDTA and propolis prevents aluminum induced toxicity in rats. Food Chem Toxicol, 50, 2487–95.
  • Bhasin P, Singla N, Dhawan DK. (2012). Protective role of zinc during aluminum-induced hepatotoxicity. Environ Toxicol, 29:320–7. doi:10.1002/tox.21760.
  • Bihaqi SW, Sharma M, Singh AP, Tiwari M. (2009). Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol, 124, 409–15.
  • Bishop NJ, Morley R, Day JP, Lucas A. (1997). Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med, 336, 1557–61.
  • Bjertness E, Candy JM, Torvik A, Ince P, McArthur F, Taylor GA, et al. (1996). Content of brain aluminum is not elevated in Alzheimer's disease. Alzheimer Dis Assoc Disord, 10, 171–4.
  • Bodhak S, Balla VK, Bose S, Bandyopadhyay A, Kashalikar U, Jha SK, Sastri S. (2011). In vitro biological and tribological properties of transparent magnesium aluminate (Spinel) and aluminum oxynitride (ALON®). J Mater Sci Mater Med, 22, 1511–19.
  • Bohrer D, Bertagnolli DC, de Oliveira SM, do Nascimento PC, de Carvalho LM, Garcia SC, et al. (2009). Role of medication in the level of aluminium in the blood of chronic haemodialysis patients. Nephrol Dial Transplant, 24, 1277–81.
  • Bohrer D, do Nascimento PC, Binotto R, Becker E. (2003). Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: Interaction container chemicals during the heating for sterilization. J Trace Elem Med Biol, 17, 107–15.
  • Bohrer D, do Nascimento PC, Binotto R, Carlesso R. (2001). Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition. J Trace Elem Med Biol, 15, 103–8.
  • Bohrer D, Oliveira SM, Garcia SC, Nascimento PC, Carvalho LM. (2010). Aluminum loading in preterm neonates revisited. J Pediatr Gastroenterol Nutr, 51, 237–41.
  • Bolle F, Brian W, Petit D, Boutakhrit K, Feraille G, Van LJ. (2011). Tea brewed in traditional metallic teapots as a significant source of lead, nickel and other chemical elements. Food Addit Contam A, 28, 1287–93.
  • Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, Zatta, P. (2011). Aluminum, copper, iron and zinc differentially alter amyloid-Aβ (1-42) aggregation and toxicity. Int J Biochem Cell Biol, 43, 877–85.
  • Bondy SC. (2010). The neurotoxicity of environmental aluminum is still an issue. Neurotoxicol, 31, 575–81.
  • Bora T, Merdivan M, Hemamei C. (2002). Levels of trace and major elements in illicit heroin. Forensic Sci, 47, 959–63.
  • Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. (2006). The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol, 3, 11.
  • Boto de los Bueis A, Pereira Vega P, Sánchez Ramos JL, Maldonado Perez JA, Averbe Garcia RA, Garcia Jiménez DG, Pujol de la Llave E. (2002). Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil. Chest, 121, 1223–30.
  • Boullemant A. (2011). PM2.5 emissions from aluminum smelters: coefficients and environmental impact. J Air Waste Manage Assoc, 61, 311–18.
  • Bower C, Stanley FJ, Nichol DJ. (1993). Maternal folate status and the risk for neural tube defects. Ann NY Acad Sci, 678, 146–55.
  • Bowler RM, Gysens S, Diamond E, Booty A, Hartney C, Roels H.A. (2003). Neurophysiological sequelae of exposure to welding fumes in a group of occupationally exposed men. Int J Hyg Environ Health, 206, 517–29.
  • Bozynski MEA, Sedman AB, Naglie RA, Wright, EJ. (1989). Serum, plasma and urinary aluminum levels and tissue loading in pre-term twins. J Parenter Enteral Nutr, 13, 428–31.
  • Bradford-Hill A. (1965). The environment and disease: association or causation? Proc R Soc Med, 58, 295–300.
  • Brady RC, Treanor JJ, Atmar RL, Keitel WA, Edelman R, Chen WH, et al. (2009). Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine, 27, 5091–5.
  • Braganca VL, Melnikov P, Zanoni LZ. (2011). Trace elements in fruit juices. Biol Trace Elem Res, 146, 256–61.
  • Bresson JL, Perronne C, Launay O, Gerdil C, Saville M, Wood J, et al. (2006). Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam 1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet, 367, 1657–64.
  • Buchta M, Kiesswetter E, Schäper M, Zschiesche W, Schaller K, Kuhlmann A, Letzel S. (2005). Neurotoxicity of exposures to aluminium welding fumes in the truck trailer construction industry. Environ Toxicol Pharmacol, 19, 677–85.
  • Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, et al. (1992). Assembly and aggregation properties of synthetic Alzheimer's A41 beta amyloid peptide analogs. J Biol Chem, 267, 546–54.
  • Burrell SA, Exley C. (2010). There is (still) too much aluminium in infant formulas. BMC Pediatr, 10, 63.
  • Bush AI, Tanzi RE. (2002). The galvanization of β-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA, 99, 7317–19.
  • Byrne JD, Baugh JA. (2008). The significance of nanoparticles in particle-induced pulmonary fibrosis. McGil J Med, 11, 43–50.
  • Calejo AI, Jorgacevski J, Silva VS, Stenovec M, Kreft M, Goncalves PP, Zorec R. (2011). Aluminum-induced changes of fusion pore properties attenuate prolactin secretion in rat pituitary lactotrophs. Neuroscience, 201, 57–66.
  • Calejo AI, Rodriguez E, Silva VS, Jorgacevski J, Stenovec M, Kreft M, et al. (2010). Life and death in aluminum-exposed cultures of rat lactotrophs studied by flow cytometry. Cell Biol Toxicol, 26, 341–53.
  • Campdelacreu J. (2012). Enfermedad de Parkinson y enfermedad de Alzheimer: factores de riesgo ambientales [Parkinson disease and Alzheimer disease: environmental risk factors]. Neurologia, [Epub ahead of print]. doi: 10.1016/j.nrl.2012.04.001.
  • CAN/CSA-ISO (Canadian Standards Association). (2011). Water for haemodialysis and related therapies (adopted ISO 13959:2009; 1st edition 2009-04-15). Mississauga, Ontario: Canadian Standards Association.
  • Cannata JB, Briggs JD, Junor BJR, Fell GS. (1983). Aluminum hydroxide intake: Real risk of aluminum toxicity. Br Med J, 286, 1937–8.
  • Cao H, Qiao L, Zhang H, Chen J. (2010). Exposure and risk assessment for aluminium and heavy metals in Puerh tea. Sci Total Environ, 408, 2777–84.
  • Card JW, Jonaitis TS, Tafazoli S, Magnuson BA. (2011). An appraisal of the published literature on the safety and toxicity of food-related nanomaterials. Crit Rev Toxicol, 41, 20–49.
  • Cárdenas O, Segura O, Puentes W, Sanabria M, Nava G, Torrenegra R. (2010). Aluminio en pacientes con terapia de reemplazo renal crónico con hemodiálisis en dos unidades renales en Bogotá. [Aluminuim in chronic renal replacement therapy patients undergoing haemodialysis in two renal units in Bogotá]. Rev Salud Pública, 12, 669–81.
  • Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, et al.; Alzheimer's Research UK , (ARUK) consortiumYounkin SG. (2011). Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Mol Neurodegener, 6, 54.
  • Castorina A, Tiralongo A, Giunta S, Carnazza ML, Scapagnini G, D’Agata V. (2010). Early effects of aluminum chloride on β-secretase mRNA expression in a neuronal model of β-amyloid toxicity. Cell Biol Toxicol, 26, 367–77.
  • CDC (US Centers for Disease Control). (2000). Data Table of Infant Weight-for-Age Charts. National Center for Health Statistics. Available at: http://www.cdc.gov/growthcharts/html_charts/wtageinf.htm [Accessed 10 June 2013].
  • CDC (Centers for Disease Control). (2008). Elevated serum aluminum levels in hemodialysis patients associated with use of electric pumps – Wyoming 2007. MMWR, 57, 689–91.
  • Chaitanya TV, Mallipeddi K, Bondili JS, Nayak P. (2012). Effect of aluminum exposure on superoxide and peroxide handling capacities by liver, kidney, testis and temporal cortex in rat. Indian J Biochem Biophys, 49, 395–8.
  • Chakrabarty M, Bhat P, Kumari S, D’Souza A, Bairy KL, Chaturvedi A, et al. (2012). Cortico-hippocampal salvage in chronic aluminum induced neurodegeneration by Celastrus paniculatus seed oil: Neurobehavioural, biochemical, histological study. J Pharmacol Pharmacother, 3, 161–71.
  • Chedid F, Fudge A, Teubner J, James SL, Simmer K. (1991). Aluminum absorption in infancy. J Paediatr Child Health, 27, 164–6.
  • Chen L, Yokel RA, Henning B, Toborek M. (2008). Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol, 3, 286–95.
  • Chen TJ, Cheng HM, Wang DC, Hung HS. (2011a). Nonlethal aluminum maltolate can reduce brain-derived neurotrophic factor-induced Arc expression through interrupting the ERK signaling in SH-SY5Y neuroblastoma cells. Toxicol Lett, 200, 67–76.
  • Chen TJ, Hung HS, Wang DC, Chen SS. (2010a). The protective effect of Rho-associated kinase inhibitor on aluminum-induced neurotoxicity in rat cortical neurons. Toxicol Sci, 116, 264–72.
  • Chen WT, Liao YH, Yu HM, Cheng IH, Chen YR. (2011b). Distinct effects of Zn2+, Cu2+, Fe3+, and Al3 + on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation. J Biol Chem, 286, 9646–56.
  • Chen BB, Zeng Y, Hu B. (2010b). Study on speciation of aluminum in human serum using zwitterionic bile acid derivative dynamically coated C18 column HPLC separation with UV and on-line ICP-MS detection. Talanta, 81, 180–6.
  • Cheng D, Zhu C, Cao J, Jiang W. (2012). The protective effects of polyphenols from jujube peel (Ziziphus jujube Mill.) on isoproterenol-induced myocardial ischemia and aluminum-induced oxidative damage in rats. Food Chem Toxicol, 50, 1302–8.
  • Childs CW, Parfitt RL, Newman RH. (1990). Structural studies of Silica Springs allophane. Clay Miner, 25, 329–41.
  • Chiu HFK, Lee HC, Chung WS, Kwong PK. (1994). Reliability and validity of the Cantonese version of the mini-mental state examination – a preliminary study. J Hong Kong Coll Psychiatrists, 4(Suppl 2), 25–8.
  • Chotpitayasunondh T, Thisyakorn U, Pancharoen C, Pepin S, Nougarede N. (2008). Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS One, 3, e4028.
  • Cifone MA, Myhr B, Eiche A, Boksfoldi G. (1987). Effects of pH shifts on the mutant frequency at the thymidine kinase locus in mouse lymphoma L5178Y TK +/- cells. Mutat Res, 189, 39–46.
  • Clapp T, Siebert P, Chen D, Jones BL. (2011). Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability. J Pharm Sci, 100, 388–401.
  • Coburn JW, Mischel MG, Goodman WG, Salusky IB. (1991). Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis, 17, 708–11.
  • Colak S, Geyikoglu F, Keles ON, Turkez H, Topal A, Unal B. (2011). The neuroprotective role of boric acid on aluminum chloride-induced neurotoxicity. Toxicol Ind Health, 27, 700–10.
  • Contini del MC, Millen N, González M, Mahieu S. (2011). Melatonin prevents oxidative stress in ovariectomized rats treated with aluminium. Biol Trace Elem Res, 144, 924–43.
  • Costa C, Conte A, Buonocore GG, Del Nobile MA. (2011). Antimicrobial silver- montmorillonite nanoparticles to prolong shelf life of fresh fruit salad. Int J Food Microbiol, 148, 164–7.
  • Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, et al. (2009). Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem, 103, 1571–8.
  • Crisponi G, Nurchi VM. (2011). Thermodynamic remarks on chelating ligands for aluminium related diseases. J Inorg Biochem, 105, 1518–22.
  • Crisponi G, Nurchi VM, Bertolasi V, Remelli M, Faa G. (2012). Chelating agents for human disease related to aluminium overload. Coord Chem Rev, 256, 89–104.
  • Crisponi G, Nurchi VM, Faa G, Remelli M. (2011). Human diseases related to aluminium overload. Montash Chem, 142, 331–40.
  • Cui X, Wang B, Zong Z, Liu S, Xing W. (2012). The effects of chronic aluminum exposure on learning and memory of rats by observing the changes of Ras/Raf/ERK signal transduction pathway. Food Chem Toxicol, 50, 315–19.
  • Curwin B, Bertke S. (2011). Exposure characterization of metal oxide nanoparticles in the workplace. J Occup Environ Hyg, 8, 580–7.
  • Czeizel AS, Dudas I. (1992). Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. N Engl J Med, 327, 1832–5.
  • Dabeka R, Fouquet A, Belisle S, Turcotte S. (2011). Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions. Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 28, 744–53.
  • Dabeka RW, McKenzie AD. (1990). Aluminium levels in Canadian infant formulae and estimation of aluminium intakes from formulae by infants 0-3 months old. Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 7, 275–82.
  • Darbre PD. (2001). Underarm cosmetics are a cause of breast cancer. Eur J Cancer Prev, 10, 389–93.
  • Darbre PD. (2006). Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol, 26, 191–7.
  • Darbre PD, Pugazhendhi D, Mannello F. (2011). Aluminum and human breast diseases. J Inorg Biochem, 105, 1484–8.
  • Dasch J, D’Arcy J. (2008). Physical and chemical characterization of airborne particles from welding operations in automotive plants. J Occup Environ Hyg, 5, 444–54.
  • Da Silva SE, Jakubovic R, Pejović-Milić A, Heyd DV. (2010). Aluminum and strontium in calcium supplements and antacids: a concern to haemodialysis patients? Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 27, 1405–14.
  • de Kom JF, Dissels HM, van der Voet GB, de Wolff FA. (1997). Serum aluminium levels of workers in bauxite mines. J Toxicol Clin Toxicol, 35, 645–51.
  • de Oliveira SR, Bohrer D, Garcia SC, do Nascimento PC, Noremberg S. (2010). Aluminum content in intravenous solutions for administration to neonates: Role of product preparation and administration methods. J Parenteral Enteral Nutr, 34, 322–8.
  • De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. (2012). Alzheimer's disease. Subcell Biochem, 65, 329–52.
  • De Veer VM, Kemp J, Chatelier J, Elhay MJ, Meeusen EN. (2010). The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine, 28, 6597–602.
  • del Pilar Martínez MM, Bozzini C, Olivera MI, Dmytrenko G, Conti MI. (2011). Aluminum bone toxicity in immature rats exposed to simulated high altitude. J Bone Miner Metab, 29, 526–34.
  • Demont M, Boutakhrit K, Fekete V, Bolle F, Van LJ. (2012). Migration of 18 trace elements from ceramic food contact material: influence of pigment, pH, nature of acid and temperature. Food Chem Toxicol, 50, 734–43.
  • Descamps D, Hardt K, Spiessens B, Izurieta P, Verstraeten T, Breuer T, Dubin G. (2009). Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum Vaccine, 5, 332–40.
  • DFG (Deutsche Forschungsgemeinschaft). (2007). List of MAK and BAT Values 2001. Aluminium – Aluminiumoxid – und Aluminiumhydroxid-haltige Stäube. Maximum Concentrations and Biological Tolerance Values at the Workplace. Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Weinheim: Wiley-VCH.
  • DFG (Deutsche Forschungsgemeinschaft). (2013). MAK- und BAT-Werte-Liste. Available at: http://www.dfg.de/download/pdf/dfg_im_profil/gremien/senat/arbeitsstoffe/mak_bat_werte_liste_2013.pdf [Accessed 10 June 2013].
  • Deveau M, Chen C-P, Johanson G, Krewski D, Maier MA, Niven KJ, et al. (2014). The global landscape of occupational exposure limits – implementation of harmonization principles to guide limit selection. J Occup Environ Hyg(in press).
  • Di Virgilio AL, Reigosa M, de Mele, MF. (2010). Response of UMR 106 cells exposed to titanium oxide and aluminum oxide nanoparticles. J Biomed Mater Res A, 92, 80–6.
  • Divine KK, Lewis JL, Grant PG, Bench, G. (1999). Quantitative particle-induced X-ray emission imaging of rat olfactory epithelium applied to the permeability of rat epithelium to inhaled aluminum. Chem Res Toxicol, 12, 575–81.
  • DiVirgilio AL, Reigosa A, Arnal PM, Fernández Lorenzo de Mele M. (2010). Comparative study of the cytotoxic and genotoxic effects of titanium dioxide and aluminum oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells. J Hazard Mater, 177, 711–18.
  • Dong E, Wang Y, Yang ST, Yuan Y, Nie H, Chang Y, et al. (2011). Toxicity of nano gamma alumina to neural stem cells. J Nanosci Nanotechnol, 11, 7848–56.
  • Donoghue AM, Frisch N, Ison M, Walpole G, Capil R, Curl C, et al. (2010). Occupational asthma in the aluminum smelters of Australia and New Zealand: 1991-2006. Am J Ind Med, 54, 224–31.
  • Donoghue AM, Frisch N, Olney D. (2014). Bauxite mining and alumina refining. Process description and health risks. J Occup Environ Med, 56(5S), S12–7.
  • Dorea JG. (2010). More on low-level non-occupational mercury exposure and health concerns. Sci Total Environ, 408, 2008–9.
  • Dorea JG. (2011). Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines. Neurochem Res, 36, 927–38.
  • Dorea JG. (2012a). Multiple toxic heavy metals and neonatal neurobehavior in China require considering co-exposure to thimerosal-ethylmercury and adjuvant-aluminum. Neurotoxicol Teratol, 34, 219.
  • Dorea JG. (2012b). Neurotoxic metal coexposures and neurodevelopment. Environ Health Perspect, 120, A226–7.
  • Dorea JG, Marques RC. (2010). Infants’ exposure to aluminum from vaccines and breast milk during the first 6 months. J Expo Sci Environ Epidemiol, 20, 598–601.
  • Drago D, Betella M, Bolognin S, Cendron L, Scancar J, Milacic R, et al. (2008). Potential pathogenic role of beta-amyloid (1-42) aluminum complex in Alzheimer's disease. Int J Biochem Cell B, 40, 731–46.
  • Drago D, Folin M, Baiquera S, Tognon G, Ricchelli F, Zatta P. (2007). Comparative effects of Abeta (1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures. J Alzheimers Dis, 11, 33–44.
  • EC (European Commission). (2005). EUR 22766 EN European Union Risk Assessment Report cadmium oxide. In: Pakalin S, Munn SJ, Aschberger K, Cosgrove O, de Coen W, Paya-Perez A, Vegro S. Part II–Human Health. Vol 75. DG Joint Research Centre, Institute of Health and Consumer Protection, European Chemicals Bureau. Luxembourg: Office for Official Publications of the European Communities. pp. 697–702.
  • EC (European Commission). (2013). Annex III. List of substances which cosmetic products may not contain except subject to restrictions laid down. EC Regulation (v.2). Available at http://ec.europa.eu/consumers/cosmetics/cosing/index.cfm?fuseaction = search.results&annex_v2 = III&search [Accessed 30 August 2013].
  • Edling NPG. (1961). Aluminum pneumoconiosis. A roentgendiagnostic study of five cases. Acta Radiol, 56, 170–8.
  • EFSA (European Food Safety Authority). (2013). Dietary exposure to aluminium-containing food additives. Supporting Publications 2013: EN-411. pp. 17. Available at: www.efsa.europa.eu/publications [Accessed on 28 May 2014].
  • EFSA (European Food Safety Authority). (2011). On the evaluation of a new study related to the bioavailability of aluminium in food. EFSA J, 9, 2157.
  • Egan PM, Belfast MT, Gimenez JA, Sitrin RD, Mancinelli RJ. (2009). Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine, 27, 3175–80.
  • Ehrlich HJ, Müller M, Oh HML, Tambyah PA, Joukhadar C, Montomoli E, et al.; Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team. (2008). A clinical trial of whole virus H5N1 vaccine derived from cell culture. N Engl J Med, 358, 2573–84.
  • Eickhoff TC, Mayers M. (2002). Workshop summary: aluminium in vaccines. Vaccine, 20, S1–4.
  • Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. (2008). Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature, 453, 1122–6.
  • El-Demerdash FM. (2004). Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminum. J Trace Elem Med Biol, 18, 113–21.
  • Elsaid FG, Shati A, Hafez E. (2011). The protective role of coffea Arabica L. and Crocus sativus L. against the neurotoxicity induced by chronic administration of aluminium chloride. J Pharmacol Toxicol, 6, 647–63.
  • El-Sayed WM, Al-Kahtani MA, Abdel-Moneim AM. (2011). Prophylactic and therapeutic effects of taurine against aluminum-induced acute hepatotoxicity in mice. J Hazard Mater, 192, 880–6.
  • Elshamaa MF, Sabry S, Mokhtar I, El-Saaid GS, Raafat M, Abd-El Haleem DA. (2010). Aluminum and lead abnormalities in children on haemodialysis: Relationship with some medications. Arch Med Sci, 6, 420–9.
  • Erazi H, Ahboucha S, Gamrani H. (2011). Chronic exposure to aluminum reduces tyrosine hydroxylase expression in the substantia nigra and locomotor performance in rats. Neurosci Lett, 487, 8–11.
  • Erkan N, Özden Ö, Ulusoy S. (2009). Levels of trace elements in commercially important fish, crustaceans and mollusks from Istanbul fish market. Fresneius Environ Bull, 18, 1307–11.
  • Exley C. (2004). The pro-oxidant activity of aluminum. Free Radic Biol Med, 36, 380–7.
  • Exley C, Ahmed U, Polwart A, Bloor RN. (2007a). Elevated urinary aluminium in current and past users of illicit heroin. Addict Biol, 12, 197–9.
  • Exley C, Begum A, Woolley MP, Bloor RN. (2006). Aluminum in tobacco and cannabis and smoking-related disease. Am J Med, 119, 276.e9–11.
  • Exley C, Burgess E, Day JP, Jeffery EH, Melethil S, Yokel RA. (1996). Aluminum toxicokinetics. J Toxicol Environ Health, 48, 569–84.
  • Exley C, Charles LM, Barr L, Martin C, Polwart A, Darbre PD. (2007b). Aluminum in human breast tissue. J Inorg Biochem, 101, 1344–6.
  • Exley C, House ER. (2011). Aluminum in the human brain. Montash Chem, 142, 357–63.
  • Exley C, House E, Patel T, Wu L, Fraser PE. (2010). Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro. J Inorg Biochem, 104, 1125–9.
  • Exley C, House E, Polwart A, Esiri MM. (2012). Brain burdens of aluminum, iron and copper and their relationships with amyloid β pathology in 60 human brains. J Alzheimers Dis, 31, 1–6.
  • Exley C, Siesjö P, Eriksson H. (2010). The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol, 31, 103–9.
  • Exley C, Swarbrick L, Gherardi RK, Authier FJ. (2009). A role for the body burden of aluminum in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses, 72, 135–9.
  • Fakri S, Al-Azzawi A, Al-Tawil N. (2006). Antiperspirant use as a risk factor for breast cancer in Iraq. Mediterr Health J, 12, 478–82.
  • Fanni D, Ambu R, Gerosa C, Nemolato S, Iacovidou N, Van Eyken P, et al. (2014). Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in prenatal and perinatal periods. World J Pediatr, 10, 101–7.
  • Fekete V, Deconinck E, Bolle F, Van LJ. (2012). Modelling aluminium leaching into food from different foodware materials with multi-level factorial design of experiments. Food Addit Contam A, 29, 1322–33.
  • Felsenfeld AJ, Gutman RA, Llach F, Harrelson JM. (1982). Osteomalacia in chronic renal failure: A syndrome previously reported only with maintenance dialysis. Am J Nephrol, 2, 147–54.
  • Fernandez-Lorenzo FJR, Cocho JA, Rey-Goldar ML, Couce M, Fraga JM. (1999). Aluminum contents of human milk, cow's milk and infant formulas. J Pediatr Gastroenterol Nutr, 28, 270–5.
  • Fewtrell MS, Bishop NJ, Edmonds CJ, Isaacs EB, Lucas A. (2009). Aluminum exposure from parenteral nutrition in preterm infants: bone health at 15-year follow-up. Pediatrics, 124, 1372–9.
  • Fewtrell MS, Edmonds CJ, Isaccs E, Bishop NJ, Lucas, A. (2011). Aluminum exposure from parenteral nutrition in preterm infants and later health outcomes during childhood and adolescence. Proc Nutr Soc, 70, 299–304.
  • Fiejka M, Fiejka E, Dlugaszek M. (1996). Effect of aluminum hydroxide administration on normal mice: Tissue distribution and ultrastructural localization of aluminium in liver. Pharmacol Toxicol, 78, 123–8.
  • Finnell RH, Greer KA, Barber RC, Piedrahita JA, Shaw GM, Lammer EJ. (1998). Neural tube and craniofacial defects with special emphasis on folate pathway genes. Crit Rev Oral Biol Med, 9, 38–53.
  • Flarend R, Bin T, Elmore D, Hem SL. (2001). A preliminary study of the dermal absorption of aluminum from antiperspirants using aluminum-26. Food Chem Toxicol, 39, 163–8.
  • Flarend RE, Hem SL, White JL, Elmore D, Suckow MA, Rudy AC, Dandashli EA. (1997). In vivo absorption of aluminum-containing vaccine adjuvants using aluminum-26. Vaccine, 15, 1314–18.
  • Flaten TP. (2002). Aluminum in tea – concentrations, speciation and bioavailability. Coord Chem Rev, 228, 385–95.
  • Flaten TP, Alfrey AC, Birchall JD, Savory J, Yokel RA. (1996). Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Environ Health, 48, 527–41.
  • Floody MC, Theng BKG, Reyes P, Mora ML. (2009). Natural nanoclays: applications and future trends – a Chilean perspective. Clay Min, 44, 161–76.
  • Florent C, Desaint B, Legendre C, Chappuis P, Galle C, Giboudeau J, de Meynard C. (1991). Morphologic and ultrastructural effects of Maalox TC on human gastric and duodenal mucosa. J Clin Gastroenterol, 13, S139–44.
  • Foglio E, Buffoli B, Exley C, Rezzani R, Rodella LF. (2012). Regular consumption of silicic acid-rich water prevents aluminum-induced alterations in nitrergic neurons in mouse brain: histochemical and immunohistochemical studies. Histol Histopathol, 27, 1055–66.
  • Fraga CG, Oteiza PI, Golub MS, Gershwin ME, Keen CL. (1990). Effects of aluminum on brain lipid peroxidation. Toxicol Lett, 51, 213–19.
  • Franchi L, Nuñez G. (2008). The Nlrp3 inflammasome is critical for aluminum hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol, 38, 2085–9.
  • Frankowski M, Ziola-Frankowska A, Kurzyca I, Novotny K, Vaculovic T, Kanicky V, et al. (2011). Determination of aluminium in groundwater samples by GF-AAS, ICP-AES, ICP-MS and modelling of inorganic aluminium complexes. Environ Monit Assess, 182, 71–84.
  • Franzmann AW, Flynn A, Arseson PD. (1976). Moose milk and hair element levels and relationships. J Wildlife Dis, 12, 202–7.
  • Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA. (1991). pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J, 60, 1190–201.
  • Freundlich M, Zilleruelo G, Abitbol C, Strauss J, Faugere MC, Malluche HH. (1985). Infant formula as a cause of aluminum toxicity in neonatal uremia. Lancet, 2, 527–9.
  • Freundlich M, Zilleruelo G, Faugere MC, Abitol A, Strauss J, Malluche HH. (1986). Treatment of aluminum toxicity in infantile uremia with deferoxamine. J Pediatr, 109, 140–3.
  • Freundlich M, Zilleruelo G, Strauss J, Abitbol C, Malluche HH. (1990). More on aluminum toxic effects in children with uremia. J Pediatr, 117, 1007–9.
  • Friesen MC, Fritschi L, Del Monaco A, Benke G, Dennekamp M, de Klerk N, et al. (2009). Relationships between alumina and bauxite dust exposure and cancer, respiratory and circulatory disease. Occup Environ Med, 66, 615–18.
  • Friesen MS, Purssell RA, Gair RD. (2006). Aluminum toxicity following iv use of oral methadone solution. Clin Toxicol, 44, 307–14.
  • Fritschi I, Hoving JL, Sim MR, Del Monaco A, MacFarlane E, McKenzie D, et al. (2008). All cause mortality and incidence of cancer in workers in bauxite mines and alumina refineries. Int J Cancer, 123, 882–7.
  • Froment DH, Buddington B, Miller NL, Alfrey AC. (1989). Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds. J Lab Clin Med, 114, 237–42.
  • FSANZ (Food Standards Australia New Zealand). (2011). 23rd Annual Australian Total Diet Study. Available at http://foodstandards.gov.au/ _srcfiles/FSANZ%2023rd%20ATDS_v5.pdf [Accessed 10 June 2013].
  • GACVS (Global Advisory Committee on Vaccine Safety). (2012). Weekly epidemiological record. Aluminum adjuvants. Wkly Epidemiol Res, 87, 282–3.
  • Galloway SM. (2000). Cytotoxicity and chromosome aberrations in vitro: Experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ Mol Mutagen, 35, 191–201.
  • Garcia EM, Lorenzo ML, Cabera C, Lopéz MC, Sanchez J. (1999). Trace element determination in different milk slurries. J Dairy Res, 66, 569–78.
  • Garcia-Patos V, Pujol RM, Alomar A, Cisteró A, Curell R, Fernández-Figueras MT, de Morgas JM. (1995). Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol, 131, 1421–4.
  • Garg S, Loghdey S, Gawkrodger DJ. (2010). Allergic contact dermatitis from aluminium in deodorants. Contact Dermatitis, 62, 57–8.
  • Garrosa M, Lianes F, Gayoso MJ. (2011). Histopathological changes in gerbil liver and kidney after aluminum subchronic intoxication. Histol Histopathol, 26, 883–92.
  • Gartner H. (1952). Etiology of corundum smelter's lung; (bauxite workers lung, Shaver's disease). Arch Ind Hyg Occup Med, 6, 339–43.
  • Gatta V, Drago D, Fincati K, Valenti MT, Dalle CL, Sensi SL, Zatta P. (2011). Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex. PLoS One, 6, e15965.
  • Gatti AM, Bosco P, Rivasi F, Bianca S, Ettore G, Gaetti L, et al. (2011). Heavy metals nanoparticles in fetal kidney and liver tissues. Front Biosci (Elite Ed), 3, 221–6.
  • Gault PM, Allen KR, Newton KE. (2006). Plasma aluminium: a redundant test for people on dialysis? Ann Clin Biochem, 42, 51–4.
  • Geyikoĝlu F, Turkez H, Bakir TO, Cicek M. (2013). The genotoxic, hepatotoxic, nephrotoxic, haematotoxic and histopathological effects in rats after aluminum chronic intoxication. Toxicol Ind Health, 29, 780–91.
  • Gherardi R, Authier F. (2012). Macrophagic myofasciitis: characterization and pathophysiology. Lupus, 21, 184–9.
  • Ghribi O, DeWitt DA, Forbes MS, Herman MM, Savory J. (2001a). Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. Brain Res, 903, 66–73.
  • Ghribi O, Herman MM, DeWitt DA, Forbes MS, Savory J. (2001b). Abeta (1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd153 and NF-κB. Brain Res Mol Brain Res, 96, 30–8.
  • Ghribi O, Herman MM, Forbes MS, DeWitt DA, Savory J. (2001c). GDNF protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochrondrial Bax translocation. Neurobiol Dis, 8, 764–73.
  • Ghribi O, Herman MM, Savory J. (2002). The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus. Neurosci Lett, 324, 217–21.
  • Giaccio L, Cicchella D, De Vivo B, Lombardi G, De Rosa M. (2011). Does heavy metals pollution affects semen quality in men? A case of study in the metropolitan area of Naples (Italy). J Geochem Explor, 112, 218–25.
  • Gibbs GW, Labrèche F. (2014). Cancer risks in aluminum reduction plant workers: a review. J Occup Environ Med, 56 (5S), S40–59.
  • Gibbs AR, Pooley FD. (1994). Fuller's earth (montmorillonite) pneumoconiosis. Occup Environ Med, 51, 644–6.
  • Gies WJ. (1911). Some objections to the use of alum baking powder. J Am Med Assoc, 57, 816–21.
  • Giorgianni CM, D’Arrigo G, Brocciaroli R, Abbate A, Spatari G, Tringali MA, et al. (2012). Neurocognitive effects in welders exposed to aluminium. Toxicol Ind Health, 30, 347–56.
  • Glenny AT, Pape CG, Waddington H, Wallace W. (1926). The antigenic value of the toxin-antitoxin precipitate of Ramon. J Pathol Bacteriol, 29, 31–40.
  • Glynn AW, Sparen A, Danielsson LG, Sundstrom B, Jorhem L. (1999). Concentration-dependent absorption of aluminum in rats exposed to labile aluminum in drinking water. J Toxicol Environ Health A, 56, 501–12.
  • Goffin V, Henry F, Pie´ard-Franchimont C, Piérard GE. (2000). Penetration enhancers assessed by corneoxenometry. Skin Pharmacol Appl Skin Physiol, 13, 280–4.
  • Golub MS, Germann SL, Han B, Keen CL. (2000). Lifelong feeding of a high aluminum diet to mice. Toxicology, 150, 107–17.
  • Golub MS, Takeuchi PE. Gershwin ME, Yoshida SH. (1993). Influence of dietary aluminum on cytokine production by mitogen-stimulated spleen cells, from Swiss Webster mice. Immunopharmacol Immunotoxicol, 15, 605–19.
  • Gomes JFP, Albuquerque PCS, Miranda RMM, Vieira MTF. (2012a).Determination of airborne nanoparticles from welding operations. J Toxicol Environ Health A, 75, 747–55.
  • Gomes JF, Albuquerque PC, Miranda RM, Santos TG, Vieira MT. (2012b). Comparison of deposited surface area of airborne ultrafine particles generated from two welding processes. Inhal Toxicol, 24, 774–81.
  • Gómez M, Esparza JL, Cabré MC, Garćia T, Domingo JL. (2008). Aluminum exposure through the diet: Metal levels in AβPP transgenic mice, a model for Alzheimer's disease. Toxicology, 249, 214–19.
  • Gómez M, Esparza JL, Noqués MR, Giralt M, Cabré M, Domingo JL. (2005). Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med, 38, 104–11.
  • González MA, Roma M, Bernal C, Alvarez ML, Carrillo MC. (2007). Involvement of oxidative stress in the impairment of biliary secretory function induced by intraperitoneal administration of aluminum to rats. Biol Trace Elem Res, 116, 329–48.
  • González-Muñoz MJ, Meseguer I, Sanchez-Reus M, Schultz A, Olivero R, Benedi J, Sánchez-Muniz FJ. (2008b). Beer consumption reduces cerebral oxidation caused by aluminum toxicity by normalizing gene expression of tumor necrotic factor alpha and several antioxidant enzymes. Food Chem Toxicol, 46, 1111–18.
  • González-Muñoz MJ, Pena A, Meseguer I. (2008a). Role of beer as a possible protective factor in preventing Alzheimer's disease. Food Chem Toxicol, 46, 49–56.
  • González-Weller D, Gutierrez AJ, Rubio C, Revert C, Hardisson A. (2010). Dietary intake of aluminum in a Spanish population (Canary Islands). J Agric Food Chem, 58, 10452–7.
  • Good DP, Perl DP, Bierer LM, Schmeidler J. (1992). Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol, 31, 286–92.
  • Goodman WG, Gilligan J, Horst R. (1984). Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia. J Clin Invest, 73, 171–81.
  • Goto N, Kato H, Maeyama J, Shibano M, Saito T, Yamaguchi J, Yoshihara S. (1997). Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties. Vaccine, 15, 1364–71.
  • Grasso G, Pietropaolo A, Spoto G, Pappalardo G, Tundo GR, Ciaccio C, et al. (2011). Copper (I) and copper (II) inhibit Abeta peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease. Chemistry, 17, 2752–62.
  • Graves AB, Rosner D, Echeverria D, Mortimer JA, Larson EB. (1998). Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease. Occup Environ Med, 55, 627–33.
  • Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB. (1990). The association between aluminum-containing products and Alzheimer's disease. J Clin Epidemiol, 43, 35–44.
  • Greger JL, Goetz W, Sullivan D. (1985). Aluminum levels in foods cooked and stored in aluminum pans, trays and foil. J Food Prot, 48, 772–7.
  • Greger JL, Radzanowski GM. (1995). Tissue aluminum distribution in growing, mature and ageing rats: Relationship to changes in gut, kidney and bone metabolism. Food Chem Toxicol, 33, 867–75.
  • Guerin T, Chekri R, Vastel Ch, Sirot V, Volatier J-L, Leblanc J-C, Noel L. (2011). Determination of 20 trace elements in fish and other seafood from the French market. Food Chem, 127, 934–42.
  • Guest WC, Silverman JM, Pokrtshevsky E, O’Neill MA, Grad LI, Cashman NR. (2011). Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J Toxicol Environ Health A, 74, 1433–59.
  • Guillard O, Fauconneau B, Olichon D, Dedieu G. (2004). Hyperaluminemia in a woman using an aluminium-containing antiperspirant for 4 years. Am J Med, 117, 956–9.
  • Guillard O, Fauconneau B, Pineau A, Marrauld A, Bellocq JP, Chenard MP. (2012). Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma. J Trace Elem Med Biol, 26, 291–3.
  • Gun RT, Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, et al. (1997). Occupational risk factors for Alzheimer's disease: a case-control study. Alzheimer Dis Assoc Disord, 11, 21–7.
  • Güngör N, Knaapen AM, Munnia A, Peluso M, Haenen GR, Chiu RK, et al. (2010). Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis, 25, 149–54.
  • Guo CH, Huang CJ, Chen ST, Hsu G-SW. (2001). Serum and testicular testosterone and nitric oxide products in aluminum-treated mice. Environ Toxicol Pharmacol, 10, 53–60.
  • Guo CH, Lin CY, Yeh MS, Hsu G-SW. (2005). Aluminum-induced suppression of testosterone through nitric oxide production in male mice. Environ Toxicol Pharmacol, 19, 33–40.
  • Guo C-H, Hsu G-SW, Chuang C-J, Chen P-C. (2009). Aluminum accumulation induced testicular oxidative stress and altered selenium metabolism in mice. Environ Toxicol Pharmacol, 27, 176–81.
  • Gupta RK. (1998). Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev, 32, 155–72.
  • Gupta VK, Agarwal S, Saleh T. (2011). Synthesis and characterization of alumina-coated carbon nanotubes and their application for lead removal. J Hazard Mater, 185, 17–23.
  • Gutteridge JMC, Quinlan GJ, Clark I, Halliwell B. (1985). Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta, 835, 441–7.
  • Guyton AJ, Hall JE. (2000). Textbook of Medical Physiology. 10th edition. London: WB Saunders.
  • Guzelian PS, Victoroff MS, Halmes NC, James RC, Guzelian CP. (2005). Evidence-based toxicology: a comprehensive framework for causation. Hum Exp Toxicol, 24, 161–201.
  • Hale LW, Gough J, King EJ, Nagelschmidt G. (1956). Pneumoconiosis of kaolin workers. Br J Ind Med, 13, 251–9.
  • Hall PL, Churchman GJ, Theng BKG. (1985). Size distribution of allophane unit particles in aqueous suspensions. Clays Clay Miner, 33, 345–9.
  • Hamdy RC. (1990). Aluminum toxicity and Alzheimer's disease. Is there a connection? Postgrad Med, 88, 239–40.
  • Hanninen H, Matikainen E, Kovala T, Valkonen S, Riihimaki V. (1994). Internal load of aluminum in the central nervous system function of aluminium welders. Scand J Work Environ Health, 20, 279–85.
  • Hannouche D, Zaoui A, Zadegan F, Sedel L, Nizard R. (2011). Thirty years of experience with alumina-on-alumina bearings in total hip arthroplasty. Int Orthop, 35, 207–13.
  • Hansen B, Belfast M, Soung G, Song L, Egan PM, Capen R, et al. (2009). Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine, 27, 888–92.
  • Hansen B, Sokolovska A, HogenEsch H, Hem SL. (2007). Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine, 25, 6618–24.
  • Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. (2009). Genome-wide association study that identifies variants of CLU and PICALM associated with Alzheimers disease. Nat Genet, 41, 1088–93.
  • Health Canada. (2007). Canadian Total Diet Study. Dietary Intakes of Contaminants and Other Chemicals for Different Age-Sex Groups of Canadians. Vancouver. Available at: http://www.hc-sc.gc.ca/fn-an/surveill/total-diet/intake-apport/chem_age-sex_chim_2007-eng.php [Accessed 10 June 2013].
  • Health Canada. (2010). Priority Substances List Assessment Report. Follow-up to the State of Science Report 2000. Aluminum chloride, aluminum nitrate, aluminum sulfate. Ottawa: Environment Canada. Available at: http://www.ec.gc.ca/CEPARegistry/documents/subs_list/Aluminium_Salts/final/Al_salts__toc.cfm [Accessed 10 June 2013].
  • Health Council of the Netherlands. (2010). Aluminium and aluminium compounds. Health-based recommended occupational exposure limit. July 15. Publ. No. 2010/050OSH. Den Haag: Health Council of the Netherlands.
  • Hellstrom HO, Mjoberg B, Mallmin H, Michaelsson K. (2005). The aluminum content of bone increases with age, but it is not higher in hip fracture cases with and without dementia compared to controls. Osteoporos Int, 16, 1982–8.
  • Hem SL, White JL. (1995). Structure and properties of aluminum-containing adjuvants. Pharm Biotechnol, 6, 249–76.
  • Hermansen JE, Badsberg JH, Kristensen T, Gundersen V. (2005). Major and trace elements in organically or conventionally produced milk. J Dairy Res, 72, 362–8.
  • Hernández-Sánchez A, Tejada-González P, Arteta-Jiménez M. (2013). Aluminium in parenteral nutrition: a systematic review. Eur J Clin Nutr, 67, 230–8.
  • Hirata-Koizumi M, Fujii S, Ono A, Hirose A, Imai T, Ogawa K, et al. (2011a). Two-generation reproductive toxicity study of aluminium sulfate in rats. Reprod Toxicol, 31, 219–30.
  • Hirata-Koizumi M, Fujii S, Ono A, Hirose A, Imai T, Ogawa K, et al. (2011b). Evaluation of the reproductive and developmental toxicity of aluminium ammonium sulfate in a two-generation study in rats. Food Chem Toxicol, 49, 1948–59.
  • Hirayama M, Satoe I, Iwashita M, Akiyama S, Takaku Y, Yamazaki M, et al. (2011). Aging effects of major and trace elements in rat bones and their mutual correlations. J Trace Elem Med Biol, 25, 73–84.
  • Hollender D, Károly-Lakatos A, Forgó P, Körtvelyesi T, Dombi G, Majer Z, et al. (2006). Al (III) binding of an octapeptide and its phosphorylated derivative. J Inorg Biochem, 100, 351–61.
  • Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. (2011). Common variants in ABCA7, MS4A6A/MS4A4E, EPHA 1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet, 43, 429–35.
  • Hou X-H, Lamberts LV, Guan G-J, D’Haese PC. (2010). Increased exposure to aluminum: Still a problem for chronic renal failure patients in East China? Trace Elem Electrolytes, 27, 10–19.
  • House E, Esiri M, Forster G, Ince PG, Exley C. (2012). Aluminium, iron and copper in human brain tissues donated to the medical research council's cognitive function and ageing study. Metallomics, 4, 56–65.
  • HSE (Health and Safety Executive). (2011). EH40/2005 Workplace Exposure Limits. Containing the list of workplace exposure limits for use with the Control of Substances Hazardous to Health Regulations (as amended). pp. 74. Available at: http://www.sheffield/ac.uk.polopoly_fs/1.136647!/file/eh402011.pdf [Accessed 10 June 2013].
  • Huang J, Wu J, Li T, Song X, Zhang B, Zhang P, Zheng X. (2011). Effect of exposure to trace elements in the soil on the prevalence of neural tube defects in a high-risk area of China. Biomed Environ Sci, 24, 94–101.
  • Hull MJ, Abraham JL. (2002). Human aluminum welding fume-induced pneumoconiosis. Hum Pathol, 33, 819–25.
  • Hutchison S, Benson RA, Gibson VB, Pollock AH, Garside P, Brewer J.M. (2012). Antigen depot is not required for alum adjuvanticity. FASEB J, 26, 1272–9.
  • Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzeimer's disease. Alzheimers Dement, 8, 1–13.
  • IARC (International Agency for Research on Cancer). (1987). Aluminum production. Overall evaluation of carcinogenicity: An updating of IARC Monographs, (Vol 1–41). Suppl 7. Lyon: World Health Organization, pp. 89–91.
  • IFA (Insitiut für Abreitsschutz der Deutschen Gesetzlichen Unfallversicherung). (2011a). GESTIS International Limit Values. Available at: http://limitvalue.ifa.dguv.de/WebForm_ueliste.aspx [Accessed 10 June 2013].
  • IFA (Insitiut für Abreitsschutz der Deutschen Gesetzlichen Unfallversicherung). (2011b). Grenzwerteliste 2011. Sicherheit und Gesundheitsschutz am Arbeitsplatz. Spitzenverband. (Institute for Occupational Safety and Health of the German Social Accident Insurance, IFA). Berlin: Deutsche Gesetzliche Unfallversicherung.
  • ILO (International Labour Organization). (2011). Chemical Exposure Limits. Available at: http://www.ilo.org/safework/info/WCMS_151534/lang--en/index.htm#P53_2427 [Accessed 10 June 2013].
  • ILSI (International Life Science Institute). (2000). The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report – ILSI Risk Science Institute workshop participants. Inhal Toxicol, 12, 1–17.
  • Ingram AJ. (1988). Soft tissue sarcoma associated with aluminum oxide ceramic total hip arthroplasty. Clin Orthop Relat Res, 235, 311–12.
  • IPCS (International Programme on Chemical Safety). (1997). Aluminum. Environmental Health Criteria 194. United Nations Environment Programme. Geneva: World Health Organization, pp. 1–214. Available at: http://www.inchem.org/documents/ehc/ehc/ehc194.htm. [Accessed 10 June 2013].
  • Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. (2011). Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease. Clin Rev Allergy Immunol, 41, 163–8.
  • JECFA (Joint FAO/WHO Expert Committee on Food Additives). (2011). Seventy-fourth meeting. Summary and conclusions. Rome, 14–23 June. JECFA/74/SC. Available at: http://www.fao.org/ag/agn/agns/jecfa_index_en.asp [Accessed 10 June 2013].
  • Jefferson T, Rudin M, Di PC. (2004). Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis, 4, 84–90.
  • Jenkins DAS, Gouldesbrough D, Smith GD, Cowie JF, Winney RJ. (1989). Can low dosage aluminum hydroxide control the plasma phosphate without bone toxicity? Nephrol Dial Transplant, 4, 51–6.
  • Jenkins W, Perone P, Walker K, Bhagavathula N, Aslam MN, DaSilva M, et al. (2011). Fibroblast response to lanthanoid metal ion stimulation: potential contribution to fibrotic tissue injury. Biol Trace Elem Res, 144, 621–35.
  • Jimenez PM, Douthat W, Orias M. (2011). Can aluminum-based binders be used safely? Semin Dial, 24, 430–1.
  • Jin P, Chen Y, Zhang SB, Chen Z. (2012). Interactions between Al1 2 X (X = Al, C, N and P) nanoparticles and DNA nucleobases/base pairs: implications for nanotoxicity. J Mol Model, 18, 559–68.
  • Johnson VJ, Kim S-H, Sharma RP. (2005). Aluminum-maltolate induces apoptosis and necrosis in neuro-2a cells: potential role for p53 signaling. Toxicol Sci, 83, 329–39.
  • Kaizer RR, Corrêa MC, Gris LR, da Rosa CS, Bohrer D, Morsch VM, Schetinger MR. (2008). Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythorcytes. Neurochem Res, 33, 2294–301.
  • Kaizer RR, Corrêa MC, Spanevello RM, Morsch VM, Mazzanti CM, Goncalves JF, Schetinger MRC. (2005). Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions. J Inorg Biochem, 99, 1865–70.
  • Kakkar V, Kaur IP. (2011). Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminum induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol, 49, 2906–13.
  • Kamalov J, Carpenter DO, Birman I. (2011). Cytotoxicity of environmentally relevant concentrations of aluminum in murine thymocytes and lymphocytes. J Toxicol, 2011, 796719. doi: 10.115512011/796719.
  • Kan W-C, Chien C-C, Wu C-C, Su S-B, Hwang J-C, Wang H-Y. (2010). Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients. Nephrol Dial Transpl, 25, 1604–8.
  • Kaneko N, Yasui H, Takada J, Suzuki K, Sakurai H. (2004). Orally administered aluminum-maltolate complex enhances oxidative stress in the organs of mice. J Inorg Biochem, 98, 2022–31.
  • Karlik SJ, Eichhorn GL, Crapper-McLachlan DR. (1980). Molecular interactions of aluminum with DNA. Neurotoxicol, 1, 83–8.
  • Karube J, Nakaishi K, Sugimoto H, Fujihira M. (1996). Size and shape of allophone particles in dispersed aqueous systems. Clays Clay Miner, 44, 485–91.
  • Kasa P, Szerdahelyi P, Wisniewski HM. (1965). Lack of topographical relationship between sites of aluminum deposition and senile plaques in Alzheimer's disease brain. Acta Neuropathol, 90, 526–31.
  • Kaste PJ, Rice BM. (2004). Novel energetic materials for the future force: the Army pursues the next generation of propellant and explosives. AMPTIAC Q, 8, 84–90.
  • Kawahara M. (2005). Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis, 8, 171–82.
  • Kawahara M, Kato-Negishi M. (2011). Link between aluminum and the pathogenesis of Alzheimer's disease: The integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis, 2011, 276–393.
  • Keitel WA, Dekker CL, Mink C, Campbell JD, Edwards KM, Patel SM, et al. (2009). Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults. Vaccine, 27, 6642–8.
  • Kelly BC, Ikonomou MG, Higgs DA, Oakes J, Dubetz C. (2008). Mercury and other trace elements in farmed and wild salmon from British Columbia. Environ Toxicol Chem, 27, 1361–70.
  • Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, et al. (2012). Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol, 130, 25–43.
  • Keshri AK, Huang J, Singh V, Choi W, Seal S, Agarwal A. (2010). Synthesis of aluminum oxide coating with carbon nanotube reinforcement produced by chemical vapor deposition for improved surface fracture and wear resistance. Carbon, 48, 431–42.
  • Khalaf AE, Morgan AM, Mekawy MM, Ali MF. (2008). Immunotoxicity following pre- and post-natal aluminum exposure in rats. Toxicol Res, 24, 51–8.
  • Kiesswetter E, Schäper M, Buchta M, Schaller KH, Rossbach B, Scherhag H, et al. (2007). Longitudinal study on potential neurotoxic effects of aluminum: I. Assessment of exposure and neurobehavioral performanceof Al welders in the train and truck construction industry over, 4 years. Int Arch Occup Environ Health, 81, 41–67.
  • Kiesswetter E, Schäper M, Buchta M, Schaller KH, Rossbach B, Kraus T, Letzel S. (2009). Longitudinal study on potential neurotoxic effects of aluminum: II. Assessment of exposure and neurobehavioral performance of Al welders in the automobile industry over, 4 years. Int Arch Occup Environ Health, 82, 1191–210.
  • Kim IS, Baek M, Choi SJ. (2010). Comparative cytotoxicity of Al2O3, CeO2, TiO2 and ZnO nanoparticles to human lung cells. J Nanosci Nanotechnol, 10, 3453–8.
  • Kirkland D, Pfuhler S, Tweats D, Aardema M, Aardema M, Corvi R, et al. (2007). How to reduce false positive results when undertaking in-vitro genotoxicity testing and thus avoidunnecessary follow-up animal tests: Report of an ECVAM workshop. Mutat Res, 628, 31–55.
  • Kirshenbaum K, Daggett V. (1995). pH-dependent conformations of the amyloid beta (1-28) peptide fragment explored using molecular dynamics. Biochemistry, 34, 7629–39.
  • Klatzo I, Wisniewski HM, Streicher E. (1965). Experimental production of neurofibrillary degeneration: 1. Light microscopic observation. J Neuropathol Exp Neurol, 24, 187–99.
  • Klein GL. (1995). Aluminum in parenteral solutions revisited – again. Am J Clin Nutr, 61, 449–56.
  • Klein GL, Coburn JW. (1994). Total parenteral nutrition and its effects on bone metabolism. Crit Rev Clin Lab Sci, 31, 135–67.
  • Klein GL, Alfrey AC, Shike M, Sherrard DJ. (1991). Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. Am J Clin Nutr, 53, 399–402.
  • Klein GL, Berquist WE, Ament ME, Coburn JW, Millner NL, Alfrey AC. (1984). Hepatic aluminum accumulation in children on total parenteral nutrition. J Pediatr Gastroenterol Nutr, 3, 740–3.
  • Klein GL, Ott SM, Alfrey AC, Sherrard DJ, Hazlet TK, Miller NL, et al. (1982). Aluminum as a factor in the bone disease of long-term parenteral nutrition. Trans Assoc Am Physicians, 95, 155–63.
  • Klein GL, Sedman AB, Heyman MB, Marathe G, Battifora HA, Worrall JL, et al. (1987). Hepatic abnormalities associated with aluminum loading in piglets. J Parenter Enteral Nutr, 11, 293–7.
  • Klimisch H-J, Andreae M, Tillmann U. (1997). A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Reg Toxicol Pharmacol, 25, 1–5.
  • Kong S, Liochev S, Fridovich I. (1992). Aluminum (III) facilitates the oxidation of NADH by the superoxide anion. Free Radic Biol Med, 13, 79–81.
  • Kongerud J, Søyseth V. (2014). Respiratory disorders in aluminium smelter workers. J Occup Environ Med, 56(5S), S60–70.
  • Koo WW, Kaplan LA, Krug-Wispe SK. (1988). Aluminum contamination of infant formulas. J Parenter Enteral Nutr, 12, 170–3.
  • Koo WW, Kaplan LA, Horn J, Tsang RC, Steichen JJ. (1986). Aluminum in parenteral nutrition solution – sources and possible alternatives. J Parenter Enteral Nutr, 10, 591–5.
  • Kool M, Fierens K, Lambrecht BN. (2011). Alum adjuvant: Some of the tricks of the oldest adjuvant. J Med Microbiol, 61(Pt 7), 927–34.
  • Kool M, Petrilli V, De ST, Rolaz A, Hammad H, Van NM, et al. (2008a). Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol, 181, 3755–9.
  • Kool M, Soullie T, Van NM, Willart MA, Muskens F, Jung S, et al. (2008b). Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med, 205, 869–82.
  • Koponen IK, Jensen KA, Schneider T. (2010). Comparison of dust released from sanding conventional and nanoparticle-doped wall and wood coatings. J Expos Sci Environ Epidemiol, 21, 450–63.
  • Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, et al. (2007). Human health risk assessment for aluminum, aluminum oxide and aluminum hydroxide. J Toxicol Environ Health B, 10 (Suppl 1): 1–269.
  • Kumar A, Prakash A, Dogra S. (2011). Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Pharmacol Rep, 63, 915–23.
  • Kumar V, Bal A, Gill KD. (2009a). Susceptibility of mitochondrial superoxide dismutase to aluminum-induced oxidative damage. Toxicology, 255, 117–23.
  • Kumar V, Bal A, Gill KD. (2009b). Aluminum-induced oxidative DNA damage recognition and cell-cycle disruption in different regions of rat brain. Toxicology, 264, 137–44.
  • Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, Akira S, et al. (2011). Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity, 34, 514–26.
  • Kushkuley J, Metkar S, Chan WK, Lee S, Shea TB. (2010). Aluminum induces neurofilament aggregation by stabilizing cross-bridging of phosphorylated c-terminal sidearms. Brain Res, 1322, 118–23.
  • Lambert JC, Amouyel P. (2011). Genetics of Alzheimers disease: new evidences for an old hypothesis? Curr Opin Genet Dev, 21, 295–301.
  • Lambrecht BN, Kool M, Willart MA, Hammad H. (2009). Mechanism of action of clinically approved adjuvants. Curr Opin Immunol, 21, 23–9.
  • Landry M, Sibbald W. (2001). From data to evidence: evaluative methods in evidence-based medicine. Respir Care, 46, 1226–35.
  • Landsberg JP, McDonald B, Watt F. (1992). Absence of aluminum in the neuritic plaque cores in Alzheimer's disease. Nature, 360, 65–8.
  • Lankoff A, Banasik A, Duma A, Ochniak E, Lisowska H, Kuszewski T, et al. (2006). A comet assay study reveals that aluminium induces DNA damage and inhibits repair of radiation-induced lesions in human peripheral blood lymphocytes. Toxicol Lett, 161, 27–36.
  • Lauricella AM, Garbossa G, Nesse A. (2001). Dissimilar behavior of lymph cells in response to the action of aluminium. In vitro and in vivo studies. Int Immunopharmacol. 1, 1725–32.
  • Leblanc JC, Guérin T, Noël L, Calamassi-Tran G, Volatier JL, Verger P. (2005). Dietary exposure estimates from the 1st French Total Diet Study. Food Addit Contam, 22, 624–41.
  • Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G. (2008). Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Cancer Epidemiol Biomarkers Prev, 17, 3170–8.
  • Lehman HK, Faden HS, Fang YV, Ballow M. (2008). A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum. J Pediatr, 152, 133–5.
  • Lemire J, Appanna VD. (2011). Aluminum toxicity and astrocyte dysfunction: A metabolic link to neurological disorders. J Inorg Biochem, 105, 1513–7.
  • Lemire J, Mailloux R, Darwich R, Auger C, Appanna, VD. (2011). The disruption of L-carnitine metabolism by aluminum toxicity and oxidative stress promotes dyslipidemia in human astrocytic and hepatic cells. Toxicol Lett, 203, 219–26.
  • Leventhal JS, Berger EM, Brauer JA, Cohen DE. (2012). Hypersensitivity reactions to vaccine constituents: a case series and review of the literature. Dermatitis, 23, 102–9.
  • Lewis RC, Gaffney SH, Le MH, Unice KM, Paustenbach DJ. (2011). Airborne concentrations of metals and total dust during solid catalyst loading and unloading operations at a petroleum refinery. Int J Hyg Environ Health, 215, 514–21.
  • Li H, Li Y, Jiao J, Hu H-M. (2011c). Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumor response. Nature Nanotechnol, 6, 645–50.
  • Li W, He Y, Wu J, Xu J. (2012a). Extraction and characterization of natural soil nanoparticles in Chinese soil. Eur J Soil Sci, 63, 754–61. doi:10.1111/j.1365-2389.2012.01480.x
  • Li X, Hu C, Zhu Y, Sun H, Li Y, Zhang Z. (2011b). Effects of aluminum exposure on bone mineral density, mineral, and trace elements in rats. Biol Trace Elem Res, 143, 378–85.
  • Li X, Zhang L, Zhu Y, Li Y. (2011a). Dynamic analysis of exposure to aluminum and an acidic condition on bone formation in young growing rats. Environ Toxicol Pharmacol, 31, 295–301.
  • Li XB, Zhang ZY, Yin LH, Schluesener HJ. (2012a). The profile of beta-amyloid precursor protein expression of rats induced by aluminum. Environ Toxicol Pharmacol, 33, 135–40.
  • Li X-W, Zhang LC, Hu CW, Gu Q-Y, She Y, Li Y-F. (2010). Effects of chronic aluminum exposure on the collage metabolism of bone and cartilage in rats. The toxic effect of aluminum on bone and cartilage in rats. Fourth Intl Conf Bioinform Biomed Eng, pp. 4.
  • Li H, Willingham SB, Ting JP, Re F. (2008). Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol, 181, 17–21.
  • Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. (2010). Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet, 375, 56–66.
  • Lidsky TI. (2014). Is the aluminum hypothesis dead? J Occup Environ Med, 56(5S), S73–9.
  • Lima P, Vasconcellos M, Montenegro R, Bahia M, Costa E, Antunes L, Burbano R. (2011). Genotoxic effects of aluminum, iron and manganese in human cells and experimental systems: A review of the literature. Hum Exp Toxicol, 30, 1435–44.
  • Lima PDL, Leite DS, Vasconcellos MC, Cavalcanti BC, Santos RA, Costa-Lotufo LV, et al. (2007). Genotoxic effects of aluminum chloride in cultured human lymphocytes treated in different phases of cell cycle. Food Chem Toxicol, 45, 1154–9.
  • Lin JL, Kou MT, Leu ML. (1996). Effect of long-term low-dose aluminum containing agents on hemoglobin synthesis in patients with chronic renal insufficiency. Nephron, 74, 33–8.
  • Lind PM, Olsen L, Lind L. (2011). Circulating levels of metals are related to carotid atherosclerosis in elderly. Sci Total Environ, 416, 80–8.
  • Lindblad EB. (2004). Aluminium compounds for use in vaccines. Immunol Cell Biol, 82, 497–505.
  • Lindquist B, Lingstrom P, Fandriks L, Birkhed D. (2011). Influence of five neutralizing products on intra-oral pH after rinsing with simulated gastric acid. Eur J Oral Sci, 119, 301–4.
  • Liu YQ, Xin TR, Liang JJ, Wang WM, Zhang YY. (2010). Memory performance, brain excitatory amino acid and acetylcholinesterase activity of chronically aluminum exposed mice in response to soy isoflavones treatment. Phytother Res, 24, 1451–6.
  • Lordan S, Higginbotham CL. (2012). Effect of serum concentration on the cytotoxicity of clay particles. Cell Biol Int, 36, 57–61.
  • Lordan S, Kennedy JE, Higginbotham C.L. (2011). Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line. J Appl Toxicol, 31, 27–35.
  • Lukiw WJ. (2010). Evidence supporting a biological role for aluminum in chromatin compaction and epigenetics. J Inorg Biochem, 104, 1010–12.
  • Lynch KM, McIver FA. (1954). Pneumoconiosis from exposure to kaolin dust: kaolinosis. Am J Pathol, 30, 1117–27.
  • Maduray K, Odhav B, Nyokong T. (2012). In vitro photodynamic effect of aluminum tetrasulfophthalocyanines on melanoma skin cancer and healthy normal skin cells. Photodiagn Photodyn, 9, 32–9.
  • Maghraoui S, Ayadi A, Audinot JN, Ammar AB, Jaafoura MH, Hili AE, et al. (2012). Role of parietal and principal gastric mucosa cells in the phenomenon of concentration of aluminum and indium. Microsc Res Tech, 75, 182–8.
  • Mahalakshmi M, Balakrishnan S, Indria K, Srinivasan M. (2012). Characteristic levels of heavy metals in canned tuna fish. J Toxicol Environ Health Sci, 4, 43–5.
  • Mahieu ST, Gionotti M, Millen N, Elías MM. (2003). Effect of chronic accumulation of aluminum on renal function, cortical renal oxidative stress and cortical renal organic anion transport in rats. Arch Toxicol, 77, 605–12.
  • Mailloux RJ, Lemire J, Appanna VD. (2011). Hepatic response to aluminum toxicity: dyslipidemia and liver diseases. Exp Cell Res, 317, 2231–8.
  • Makjanic J, McDonald B, Li-Hsian Chen CP, Watt F. (1998). Absence of aluminum in neurofibrillary tangles in Alzheimer's disease. Neurosci Lett, 240, 123–6.
  • Malluche HH, Faugere MC. (1985). Aluminum: toxin or innocent bystander in renal osteodystrophy. Am J Kidney Dis, 6, 336–41.
  • Manna GK, Das RK. (1972). Chromosome aberrations in mice induced by aluminum chloride. Nucleus, 15, 180–6.
  • Mannello F, Tonti GA, Medda V, Simone P, Darbre PD. (2011). Analysis of aluminium content and iron homeostasis in nipple aspirate fluids for healthy women and breast cancer-affected patients. J Appl Toxicol, 31, 262–9.
  • Manzoli L, De VC, Salanti G, D’Addario M, Villari P, Ioannidis JP. (2011). Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PloS One, 6, e24384.
  • Manzoli L, Salanti G, De Vito C, Boccia A, Ioannidis JP, Villari P. (2009). Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. Lancet Infect Dis, 9, 482–92.
  • Maquire-Boyle SJ, Liga MV, Li Q, Barron AR. (2012). Alumoxane/ferroxane nanoparticles for the removal of viral pathogens: the importance of surface functionality to nanoparticle activity. Nanoscale, 4, 5627–32.
  • Marques RC, Dorea JG, Bernardi JV. (2010). Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months. Acta Paediatr, 99, 934–9.
  • Marrack P, McKee AS, Munks MW. (2009). Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol, 9, 287–93.
  • Martin SC, Larivière C. (2014). Community health risk assessment of primary aluminum smelter emissions. J Occup Environ Med, 56(5S), S18–22.
  • Mayeux G, Xhauflaire-Uhoda E, Pierard GE. (2012). Patterns of aluminum hydroxychloride deposition onto the skin. Skin Res Technol, 18, 64–9.
  • McGrath KG. (2003). An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev, 12, 479–85.
  • McGrath KG. (2009). Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and phermones as a link to the observed incidence rates of breast and prostate cancer in the 20th century. Med Hypotheses, 72, 665–74.
  • McGregor SJ, Naves ML, Oria R, Brock JH. (1990). Effect of aluminum on iron uptake and transferrin-receptor expression by human erythroleukemia K562 cells. Biochem J, 272, 377–82.
  • McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P. (2009). Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol, 183, 4403–14.
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology, 34, 939–44.
  • McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging – Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7, 263–9.
  • McKinnon AJ, Cattrall RW, Scollary GR. (1992). Aluminum in wine – its measurement and identification of major sources. Am J Enol Vitic, 43, 166–70.
  • Mendez-Alvarez E, Soto-Otero R, Hermida-Ameijeiras A, Lopez-Real AM, Labandeira-Garcia JL. (2002). Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease. Biochim Biophys Acta, 1586, 155–68.
  • Meurman JH, Kuittinen T, Kangas M, Tuisku T. (1988). Buffering effect of antacids in the mouth – a new treatment for dental erosion? Scand J Dent Res, 96, 412–17.
  • Meyer-Baron M, Schäper M, Knapp G, van Thriel C. (2007). Occupational aluminum exposure: evidence to support its neurobehavioral impact. Neurotoxicology, 28, 1068–78.
  • Mikkelsen L, Jensen KA, Koponen IK, Saber AT, Wallin H, Loft S, et al. (2012). Cytotoxicity, oxidative stress and expression of adhesion molecules in human umbilical vein endothelial cells exposed to dust from paints with or without nanoparticles. Nanotoxicol, 7, 117–34.
  • Millour S, Noel L, Kadar A, Chekri R, Vastel Ch, Sirot V, et al. (2011). Pb, Hg, Cd, As, Sb and Al levels in foodstuffs from the 2nd French total diet study. Food Chem, 126, 1787–99.
  • Ministry of Agriculture, Fisheries and Food. (1999). Metals and other elements in infant foods. United Kingdom Food Surveillance Information Sheet No. 190. http://archive.food.gov.uk/maff/archive/food/infsheet/1999/no190/190htm [Accessed 3 July 2014].
  • Mirick DK, Davis S, Thomas DB. (2002). Antiperspirant use and the risk of breast cancer. J Natl Cancer Inst, 94, 1578–80.
  • Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. (1991). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479–86.
  • Mitkus R, King D, Hess MA, Forshee R, Walderhaug MO. (2011)Updated aluminum pharmacokinetics following infant exposures through diet and vaccination. Vaccine, 29, 9538–43.
  • Miu AC, Olteanu AI, Miclea M. (2004). A behavioral and ultrastructural dissection of the interference of aluminum with aging. J Alzheimers Dis, 6, 315–28.
  • Mizoroki T, Meshitsuka S, Maeda S, Murayama M, Sahara N, Takashima A. (2007). Aluminum induces tau aggregation in vitro but not in vivo. J Alzheimers Dis, 11, 419–27.
  • Molloy DW, Standish TI, Nieboer E, Turnbull JD, Smith SD, Dubois S. (2007). Effects of acute exposure to aluminum on cognition in humans. J Toxicol Environ Health A, 70, 2011–19.
  • Monteiro-Riviere NA, Oldenburg SJ, Inman AO. (2010). Interactions of aluminum nanoparticles with human epidermal keratinocytes. J Appl Toxicol, 30, 276–85.
  • Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA. (2000). Absorption of aluminum-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord, 11, 66–9.
  • Morefield GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, Hem SL. (2005). Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine, 23, 1588–95.
  • Morita T, Nagaki T, Fukuda I, Okamura K. (1992). Clastogenicity of low pH to various cultured mammalian cells. Mutat Res, 268, 297–305.
  • Morita T, Watanabe Y, Takeda K, Okumura K. (1989). Effects of pH on the in vitro chromosome aberration test. Mutat Res, 225, 55–60.
  • Moselhy W, Helmy N, Abdel-Halim B, Nabil T, Abdel-Hamid M. (2011). Role of ginger against the reproductive toxicity of aluminum chloride in albino male rats. Reprod Domest Anim, 47, 335–43.
  • Mudge DW, Johnson DW, Hawley CM, Campbell SB, Isbel NM, van Eps CL, Petrie JJ. (2011). Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice? BMC Nephrol, 12, 20.
  • Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT. (1996). A newly identified polymorphism in the apolipoprotein E enhancer gene is associated with Alzheimer's disease and strongly with the ε4 allele. Neurology, 47, 196–201.
  • Mujika JI, Lopez X, Rezabal E, Castillo R, Mart S, Moliner V, Ugalde JM. (2011b). A QM/MM study of the complexes formed by aluminum and iron with serum transferrin at neutral and acidic pH. J Inorg Biochem, 105, 1446–56.
  • Mujika JI, Ruiperez F, Infante I, Ugalde JM, Exley C, Lopez X. (2011a). Pro-oxidant activity of aluminum: stabilization of the aluminum superoxide radical ion. J Phys Chem A, 115, 6717–23.
  • Mujika JI, Ugalde JM, Lopez X. (2012b). Aluminum speciation in biological environments. The deprotonation of free and aluminum bound citrate in aqueous solution. Phys Chem Chem Phys, 14, 12465–75.
  • Mujika JI, Escribano B, Akhmatskaya E, Ugalde JM, Lopez X. (2012a). Molecular dynamics simulations of iron- and aluminum-loaded serum transferrin: protonation of tyr188 is necessary for prompt metal release. Biochemistry, 51, 7017–27.
  • Murdock RC, Bradydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. (2008). Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci, 101, 239–53.
  • Nagasawa K, Ito S, Kakuda T, Nagai K, Tamai I, Tsuji A, Fujimoto S. (2005). Transport mechanism for aluminum citrate at the blood-brain barrier: kinetic evidence implies involvement of system Xc- in immortalized rat brain endothelial cells. Toxicol Lett, 155, 289–96.
  • Naim JO, van Oss CJ, Wu W, Giese RF, Nickerson PA. (1997)Mechanisms of adjuvancy: I. Metal oxides as adjuvants. Vaccine, 15, 1183–93.
  • Najafpour MM, Pashaei B, Nayeri S. (2012). Nano-sized layered aluminum or zinc-manganese oxides as efficient water oxidizing catalysts. Dalton Trans, 41, 7134–40.
  • Namer M, Luporsi E, Gligorov J, Lokiec F, Spielman M. (2008). L'utilisation de deodorants/antitranspirants ne constitue pas un risqué de cancer du sein. Bull Cancer, 95, 871–80.
  • National Kidney Foundation. (2003). K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 42, S1–202.
  • Nayak P, Sharma SB, Chowdary NV. (2010). Augmentation of aluminum-induced oxidative stress in rat cerebrum by presence of pro-oxidant (graded doses of ethanol) exposure. Neurochem Res, 35, 1681–90.
  • Nayak P, Sharma SB, Chowdary NVS. (2011). Impact of coexposure to aluminum and ethanol on phosphoesterases and transaminases of rat cerebrum. J Med Biochem, 30, 25–32.
  • Nday CM, Drever BD, Salifoglou T, Platt B. (2010). Aluminum does not enhance β-amyloid toxicity in rat hippocampal cultures. Brain Res, 1352, 265–76.
  • Nel A, Xia T, Mädler L, Li N. (2006). Toxic potential of materials at the nanolevel. Science, 311, 622–7.
  • Netterlid E, Hindsen M, Siemund I, Bjork J, Werne S, Jacobsson H, et al. (2013). Does allergen-specific immunotherapy induce contact allergy to aluminium? Acta Derm Venereol, 93, 50–6.
  • Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. (1999). Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer's disease. J Neuropathol Exp Neurol, 58, 1147–55.
  • Niedowicz DM, Nelson PT, Murphy MP. (2011). Alzheimer's disease: pathological mechanisms and insights. Curr Neuropharmacol, 9, 674–84.
  • Niemoeller OM, Kiedaisch V, Dreischer P, Wieder T, Lang F. (2006). Stimulation of eryptosis by aluminum ions. Toxicol Appl Pharmacol, 217, 168–75.
  • NIOSH (National Institute for Occupational Safety and Health). (2011). Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide. Cincinnati: Department of Health and Human Services. pp. 119.
  • Nishanth RP, Jyotsna RG, Schlager JJ, Hussain SM, Reddanna P. (2011). Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFκB signaling pathway. Nanotoxicology, 5, 502–16.
  • Noe SM, Green MA, HogenEsch H, Hem SL. (2010). Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine, 28, 3588–94.
  • Nøkleby H. (2007). Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine. Expert Rev Vaccines, 6, 863–9.
  • Nordic Expert Group for Criteria Documentation of Health Risks from Chemicals and the Dutch Expert Committee on Occupational Safety. (2011). 145. Aluminium and aluminium compounds. Arbete och Hälsa; Vetenskaplig skriftserie, 45, 1–142.
  • NRC (National Research Council). (2007). Toxicity Testing in the 21st Century: A Vision and Assessment of Environmental Agents. Washington, D.C.: National Academies Press. pp. 1–216.
  • Oakley GP. (1993). Folic acid-preventable spina bifida and anencephaly. J Am Med Assoc, 269, 1292–3.
  • Oakley GP. (2002). Global prevention of all folic acid-preventable spina bifida and anencephaly by 2010. Community Genet, 5, 70–7.
  • Oberdörster G. (1995). Lung particle overload: implications for occupational exposure to particles. Regul Toxicol Pharmacol, 21, 123–35.
  • Oberdörster G, Oberdörster E, Oberdörster J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect, 113, 823–39.
  • Oesterling E, Chopra N, Gavalas V, Arzuaga X, Lim EJ, Sultana R, et al. (2008). Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol Lett, 178, 160–6.
  • Ogimoto M, Suzuki K, Kabashima J, Nakazato M, Uematsu Y. (2012). [Aluminum content in foods with aluminum-containing food additives] (Japanese). Shokuhin Eiseigaku Zasshi, 53, 57–62.
  • Ohno K, Ishikawa K, Kurosawa Y, Matsui Y, Matsushita T, Magara Y. (2010). Exposure assessment of metal intakes from drinking water relative to those from total diet in Japan. Water Sci Technol, 62, 2694–701.
  • Olabanji O, Ngila JC, Msagati TAM, Oluyemi EA, Fatoye FO, Mamba BB. (2011). Effect of metal poisoning and the implications of gender and age on the elemental composition in patients with mental behavioural disorders. Afr J Biotechnol, 10, 3585–93.
  • Oldham PD. (1983). Pneumoconiosis in Cornish china clay workers. Br J Ind Med, 40, 131–7.
  • Orihuela D. (2011). Aluminum effects on thyroid gland function: Iodide uptake, hormone biosynthesis and secretion. J Inorg Biochem, 105, 1464–8.
  • OSHA (Occupational Safety and Health Administration). (1993). Air contaminants. Final rule, 29 CFR Part 1910. Federal Register, 58, 35338–51.
  • Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ. (1982). The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med, 307, 709–13.
  • Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, et al. (1996). 5, 10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet, 63, 610–14.
  • Pan SY, Morrison H, Gibbons L, Zhou J, Wen SW, DesMeules M, Mao Y. (2011). Breast cancer risk associated with residential proximity to industrial plants in Canada. J Occup Environ Med, 53, 522–9.
  • Pan X, Redding JE, Wiley PA, Wen L, McConnell JS, Zhang B. (2010). Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay. Chemosphere, 79, 113–16.
  • Passeri E, Villa Ch, Couette M, Itti E, Brugieres P, Cesaro P, et al. (2011). Long-term follow up on cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). J Inorg Biochem, 105, 1457–63.
  • Patra AK, Dutta A, Bhaumik A. (2012). Self-assembled mesoporous γ-Al2O3 spherical nanoparticles and their efficiency for removal of arsenic from water. J Hazard Mater, 201–202, 170–7.
  • Pauluhn J. (2009a). Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci, 109, 152–67.
  • Pauluhn J. (2009b). Retrospective analysis of 4-week inhalation studies in rats with focus on fate and pulmonary toxicity of two nanosized aluminum oxyhydroxides (boehmite) and pigment-grade iron oxide (magnetite): The key metric of dose is particle mass and not particle surface area. Toxicology, 259, 140–8.
  • Pauluhn J. (2009c). Comparative pulmonary response to inhaled nanostructures: considerations on test design and endpoints. Inhal Toxicol, 21(S1), 40–54.
  • Pauluhn J. (2011). Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology, 279, 176–88.
  • Pechansky F, Kessler FH, Diemen L, Bumaquin DB, Surratt HL, Inciardi JA. (2007). Brazilian female crack users show elevated serum aluminum levels. Rev Bras Psiquiatr, 29, 39–42.
  • Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, et al. (1995). Risk factors for renal osteodystrophy: A multivariant analysis. J Bone Miner Res, 10, 149–56.
  • Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G, Manuel A, et al. (1992). Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int, 41, 1374–82.
  • Pennington JA. (1987). Aluminum content of foods and diet. Food Addit Contam, 5, 161–232.
  • Pennington JA, Schoen SA. (1995). Estimates of dietary exposure to aluminium. Food Addit Contam, 12, 119–28.
  • Pepper R, Campbell N, Yaqoob MM, Roberts NB, Fan SL-S. (2011). Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels? BMC Nephrology, 12, 55.
  • Percy ME, Kruck TPA, Pogue AI, Lukiw WJ. (2011). Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. J Inorganic Biochem, 105, 1505–12.
  • Perl DP, Good PF. (1987). Uptake of aluminum into central nervous system along nasal-olfactory pathways. Lancet, 1, 1028.
  • Perl DP, Moalem S. (2006). Aluminum and Alzhiemer's disease, a personal prespective after 25 years. J Alzheimer's Dis, 9, 291–300.
  • Pfefferkorn FE, Bello D, Haddad G, Park J-Y, Powell M, McCarthy J, et al. (2010). Characterization of exposures to nanoscale particles during friction stir welding of aluminum. Ann Occup Hyg, 54, 486–503.
  • Phillips TD. (1999). Dietary clay in the chemoprevention of aflatoxin-induced disease. Toxicol Sci, 52, 118–26.
  • Phillips TD, Afriyie-Gyawu E, Williams J, Huebner H, Ankrah NA, Ofori-Adjei D, et al. (2008). Reducing human exposure to aflatoxin through the use of clay: A review. Food Addit Contam, 25, 134–45.
  • Piérard-Franchimont C, Arrese-Estrada J, Quatresooz P, Piérard GE. (2010). Cyanoacrylate skin surface strippings. In: Farage MA, Miller KW, Maibach HI, eds. Textbook of Aging Skin. Berlin: Springer Verlag, pp. 393–9.
  • Pineau A, Guillard O, Fauconneau B, Favreau F, Marty MH, Gaudin A, et al. (2012). In vitro study of percutaneous absorption of aluminum from antiperspirants through human skin in the Franz diffusion cell. J Inorg Biochem, 110, 21–6.
  • Poirier J, Semple H, Davies J, Lapointe R, Dziwenka M, Hiltz M, Mujibi D. (2011). Double-blind, vehicle-controlled randomized twelve month neurodevelopmental toxicity study of common aluminum salts in the rat. Neuroscience, 193, 338–62.
  • Polizzi S, Pira E, Ferrara M, Bugiani M, Papaleo A, Albera R, Palmi S. (2002). Neurotoxic effects of aluminum among foundry workers and Alzheimer's disease. Neurotoxicology, 23, 761–74.
  • Poole RL, Hintz SR, Mackenzie NI, Kerner JA. (2008). Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. J Parenter Enteral Nutr, 32, 242–6.
  • Poole RL, Pieroni KP, Gaskari S, Dixon TK, Park K, Kerner JA Jr. (2011). Aluminum in pediatric parenteral nutrition products: measured versus labeled content. J Pediatr Pharmacol Ther, 16, 92–7.
  • Poole RL, Schiff L, Hintz SR, Wong A, Mackenzie N, Kerner JA Jr. (2010). Aluminum content of parenteral nutrition in neonates: measured versus calculated levels. J Pediatr Gastroenterol Nutr, 50, 208–11.
  • Popinska K, Ksiazyk J, Friedman-Gruszczynska J, Nowicka E, Migdal A, Pietraszek E. (2010). Aluminum concentration in serum of children on long-term parenteral nutrition and in parenteral nutrition solution components. E Spen Eur E J Clin Nutr Metab, 5, e18–20.
  • Potter H, Wisniewski T. (2012). Apolipoprotein E: essential catalyst of the Alzheimer amyloid cascade. Int J Alz Dis, 2012, 489428.
  • Powers CM, Bale AS, Kraft AD, Makris SL, Trecki J, Cowden J, et al. (2013). Developmental neurotoxicity of engineered nanomaterials: identifying research needs to support human health risk assessment. Toxicol Sci, 134, 225–42.
  • Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. (2006). Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci, 90, 296–303.
  • Prabhakar PV, Reddy UA, Singh SP, Balasubramanyam A, Rahman MF, Indu KS, et al. (2011)Oxidative stress induced by aluminum oxide nanomaterials after acute oral treatment in Wistar rats. J Appl Toxicol, 32, 436–45.
  • Precioso AR, Miraglia JL, Campos LM, Goulart AC, Timenetsky MC, Cardoso MR, et al. (2011). A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. Vaccine, 29, 8974–81.
  • Priest ND. (2004). The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update. J Environ Monit, 6, 375–403.
  • Priest ND. (2010a). The bioavailability of ingested aluminium and aluminium compounds in the rat:citrate; chloride; nitrate; sulphate; hydroxide; oxide; metal; pot electrolyte. Atomic Energy of Canada Ltd. Draft Report. 14 March. A study conducted at the request of the Aluminium REACH Consortium. Chalk River: Atomic Energy of Canada Ltd.
  • Priest ND. (2010b). The bioavailability of ingested Al-26 labelled aluminium and aluminium compounds in the rat. General Nuclear Product GNP-121100-REPT-003. July. Chalk River: Atomic Energy of Canada Ltd.
  • Priest ND, Talbot JR, Austin JG, Day JP, King SJ, Fifield K, Cresswell RG. (1996). The bioavailability of 26Al-labelled aluminum citrate and aluminum hydroxide in volunteers. BioMetals, 9, 221–8.
  • Quatrale RP. (1985). Mechanism of antiperspirant action. Cosmet Toiletries, 100, 23–6.
  • Rabe A, Lee MH, Shek J, Wisniewski HM. (1982). Learning deficit in immature rabbits with aluminum-induced neurofibrillary changes. Exp Neurol, 76, 441–6.
  • Radzium E, Dudkiewicz-Wilczyńska J, Ksiaźek I, Nowak K, Anuszewska EL, Kunicki A, et al. (2011). Assessment of the cytotoxicity of aluminum oxide nanoparticles on selected mammalian cells. Toxicol In Vitro, 25, 1694–700.
  • Ranau R, Oehlenschläger J, Steinhart H. (2001). Aluminium levels of fish fillets baked or grilled in aluminum foil. Food Chem, 73, 1–6.
  • Rao VS, Cupples LA, van Duijn CM, Kurz A, Green RC, Chui H, et al. (1996). Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apoliprotein E4. Am J Hum Genet, 59, 664–75.
  • Rawlings W, Kennedy T, Menkes H, Morgan R. (1983). Pulmonary functions and respiratory symptoms in a population of Georgia kaolin workers. Am Rev Respir Dis, 127, 215–20.
  • Reza SM, Palan MJ. (2006). Effect of aluminum on testosterone hormones in male rat. J Med Sci, 6, 296–9.
  • Rezabal E, Mercero JM, Lopez X, Ugalde JM. (2007). A theoretical study of the principles regulating the specificity for Al (III) against Mg (II) in protein cavities. Chem Phys Chem, 8, 2119–24.
  • Ribes D, Colomina MT, Vicens P, Domingo JL. (2010). Impaired spatial learning and unaltered neurogenesis in a transgenic model of Alzheimer's disease after oral aluminum exposure. Curr Alzheimer Res, 7, 401–8.
  • Ribes D, Torrente M, Vicens P, Colomina MT, Gomez M, Domingo JL. (2011). Recognition memory and β-amyloid plaques in adult Tg2576 mice are not modified after oral exposure to aluminum. Alzheimer Dis Assoc Disord, 26, 179–85.
  • Ricchelli F, Drago D, Filippi B, Tognon G, Zatta, P. (2005). Aluminum-triggered structural modifications and aggregation of β-amyloids. Cell Mol Life Sci, 62, 1724–33.
  • Riihimäki V, Aitio A. (2012). Occupational exposure to aluminum and its biomonitoring in perspective. Crit Rev Toxicol, 42, 827–53.
  • Riihimäki V, Hanninen H, Akila R, Kovala T, Kuosma E, Paakkulainen H, et al. (2000). Body burden of aluminum in relation to central nervous system function among metal inert-gas welders. Scand J Work Environ Health, 26, 118–30.
  • Riihimäki V, Valkonen S, Engstrom B, Tossavainen A, Mutanen P, Aitio A. (2008). Behavior of aluminum in aluminum welders and manufacturers of aluminum sulfate – impact on biological monitoring. Scand J Work Environ Health, 34, 451–62.
  • Rimaniol AC, Gras G, Verdier F, Capel F, Grigoriev VB, Porcheray F, et al. (2004). Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine, 22, 3127–35.
  • Roberts NB, Clough A, Bellia JP, Kim JY. (1998). Increased absorption of aluminum from a normal dietary intake in dementia. J Inorg Biochem, 69, 171–6.
  • Robertson JA, Felsenfeld AJ, Haygood CC, Wilson P, Clarke C, Llach F. (1983). Animal model of aluminum-induced osteomalacia: Role of chronic renal failure. Kidney Int, 23, 327–35.
  • Rocha MS, Lucci CM, Longo JP, Galera PD, Simioni AR, Lacava ZG, et al. (2012). Aluminum-chloride-phthalocyanine encapsulated in liposomes: activity against naturally occurring dog breast cancer cells. J Biomed Nanotechnol, 8, 251–7.
  • Rödelsperger K, Brückel B, Manke J, Woitowitz H-J, Pott F. (1987). Potential health risks from the use of fibrous mineral absorption granulates. Br J Ind Med, 44, 337–43.
  • Romanowski B, Schwarz TF, Ferguson LM, Peters K, Dionne M, Schulze K, et al. (2011). Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study. Hum Vaccines, 7, 1374–86.
  • Rose M, Baxter M, Brereton N, Baskaran C. (2010). Dietary exposure to metals and other elements in the 2006 UK Total Diet Study and some trends over the last 30 years. Food Addit Contam A, 27, 1380–404.
  • Rosenlof K, Fyhrquist F, Tenhunen R. (1990). Erythropoietin, aluminum and anemia in patients on hemodialysis. Lancet, 1, 247–9.
  • Rossbach B, Buchta M, Csanady GA, Filser JG, Hilla W, Windorfer K. (2006). Biological monitoring of welders exposed to aluminum. Toxicol Lett, 162, 239–45.
  • Rui D, Yongjian Y. (2010). Aluminum chloride induced oxidative damage on cells derived from hippocampus and cortex of ICR mice. Brain Res, 1324, 96–102.
  • Rusina R, Matej R, Kasparova L, Kukal J, Urban P. (2011). Higher aluminum concentration in Alzheimer's disease after Box-Cox data transformation. Neurotox Res, 20, 329–33.
  • Ryu RK, Bovill EG, Skinner HB, Murray WR. (1987). Soft tissue sarcoma associated with aluminum oxide ceramic total hip arthroplasty. Clin Orthop Relat Res, 216, 207–12.
  • Sadiq MI, Chowdhury B, Chandrasekaran N, Mukherjee A. (2009). Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles. Nanomed Nanotechnol Biol Med, 5, 282–6.
  • Safe Work Australia. (2012). Hazardous Substances Information System (HSIS). Available at: http://hsis.safeworkaustralia.gov.au/ExposureStandards [Accessed 10 June 2013].
  • Sakula A. (1961). Pneumoconiosis due to Fuller's earth. Thorax, 16, 176–9.
  • Salib E, Hillier V. (1996). A case-control study of Alzheimer's disease and aluminum occupation. Br J Psychiatry, 168, 244–9.
  • Saiyed SM, Yokel RA. (2005). Aluminum content of some foods and food products in the USA, with aluminum food additives. Food Addit Contam, 22, 234–44.
  • Salusky IB, Coburn JW, Nelson P, Goodman WG. (1990). Prospective evaluation of aluminum loading from formula in infants with uremia. J Pediatr, 116, 726–9.
  • Salusky IB, Coburn JW, Paunier L, Sherrard DJ, Fine RN. (1984). Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. J Pediatr, 105, 717–20.
  • Salusky IB, Foley J, Nelson P, Goodman WG. (1991). Aluminum accumulation during treatment with aluminum hydroxide and dialysis in childrenand young adults with chronic renal disease. N Engl J Med, 324, 527–31.
  • Sánchez-Iglesias S, Méndez-Álvarez E, Iglesias-Gonzáles J, Muñoz-Patiño A, Sánchez-Sellero I, Labandiera-Garciá JL, Soto-Otero R. (2009). Brain oxidative stress and selective behaviour of aluminum in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease. J Neurochem, 109, 879–88.
  • Sandhu G, Djebali D, Bansal A, Chan G, Smith SD. (2011). Serum concentrations of aluminum in hemodialysis patients. Am J Kidney Dis, 57, 523–5.
  • Sandora TJ, Pfoh E, Lee GM. (2009). Adverse events after administration of tetanus- diphtheria-acellular pertussis vaccine to healthcare workers. Infect Control Hosp Epidemiol, 30, 389–91.
  • SanMartín CD, Paula-Lima AC, Hidalgo C, Núñez MT. (2012). Sub-lethal levels of amyloid beta-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons. Biometals, 25, 805–13.
  • Santibáñez M, Bolumar F, García AM. (2007). Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies. Occup Environ Med, 64, 723–32.
  • Sappino AP, Buser R, Lesne L, Gimelli S, Bena F, Belin D, Mandriota SJ. (2012). Aluminium chloride promotes anchorage-independent growth in human mammary epithelial cells. J Appl Toxicol, 32, 233–43.
  • Sato K, Suzuki I, Kubota H, Furusho N, Inoue T, Yasukouchi Y, Akiyama H. (2014). Estimation of daily aluminum intake in Japan based on food consumption inspection results: impact of food additives. Food Sci Nutr,doi: 10.1002/fsn3.114.
  • Savory J, Ghribi O. (2007). Can studies of aluminum toxicity in vivo and in vitro provide relevant information on the pathogenesis and etiology of Alzheimer's disease? J Alzheimers Dis, 11, 429–30.
  • Savory J, Herman MM, Ghribi O. (2006). Mechanisms of aluminum-induced neurodegeneration in animals: implications for Alzheimer's disease. J Alzheimers Dis, 10, 135–44.
  • Savory J, Rao JK, Huang Y, Letada PR, Herman MM. (1999). Age-related changes hippocampal changes in Bcl:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: Increased susceptibility with aging. Neurotoxicology, 20, 805–17.
  • Schenk RU, Bjorksten J, Yeager L. (1989). Composition and consequences of aluminum in water, beverages and other ingestibles. In: Lewis TE, ed. Environmental Chemistry and Toxicology of Aluminum. Chelsea, MI: Lewis Publishers. pp. 247–69.
  • Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, et al. (2009). “ToxRTool”, a new tool to assess the reliability of toxicological data. Toxicol Lett, 189, 138–44.
  • Schneider J, Walter D, Brückel B, Rödelsperger K. (2013). Primary particles and their agglomerate formation as modifying risk factors of nonfibrous nanosized dust. J Toxicol Environ Health A, 76, 131–41.
  • Schönholzer KW, Sutton RA, Walker VR, Sossi V, Schulzer M, Orvig C, et al. (1997). Intestinal absorption of trace amounts of aluminum in rats studied with 26aluminum and accelerator mass spectrometry. Clin Sci, 92, 379–83.
  • Schrag M, Crofton A, Zabel M, Jiffry A, Kirsch D, Dickson A, et al. (2011). Effect of cerebral amyloid angiopathy on brain iron, copper and zinc in Alzheimer's disease. J Alzheimer Dis, 24, 137–49.
  • Seo J, Lee TJ, Ko S, Yeo H, Kim S, Noh T, et al. (2012). Heirarchal and multifunctional three-dimensional network of carbon nanotubes for microfluidic applications. Adv Mater, 24, 1975–9.
  • Sharma D, Sethi P, Hussain E, Singh R. (2009). Curcumin counteracts the aluminium-induced ageing-related alterations in oxidative stress, Na+ K+ ATPase and protein kinase C in adult and old rat brain regions. Biogerontology, 10, 489–502.
  • Shati AA, Elsaid FG, Hafez EE. (2011). Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup. Neurosci, 175, 66–74.
  • Shirodkar S, Hutchinson RL, Perry DL, White JL, Hem SL. (1990). Aluminum compounds used as adjuvants in vaccines. Phar Res, 7, 1282–8.
  • Shoenfeld Y, Agmon-Levin N. (2011). ‘ASIA’ - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun, 36, 4–8.
  • Shrivastava S. (2012). Combined effect of HEDTA and selenium against aluminum induced oxidative stress in rat brain. J Trace Elem Med Biol, 26, 210–14.
  • Siegrist CA. (2005). Vaccine adjuvants and macrophagic myofasciitis. Arch Pediatr, 12, 96–101.
  • Sjogren B, Gustavsson P, Hogstedt C. (1990). Neuropsychiatric symptoms among welders exposed to neurotoxic metals. Br J Ind Med, 47, 704–7.
  • Slanina P, Falkeborn Y, Frech W, Cedergren A. (1984). Aluminum concentrations in the brain and bone of rats fed citric acid, aluminum citrate and aluminum hydroxide. Food Chem Toxicol, 22, 391–7.
  • Small GW, Ercoli LM, Silverman DHS, Huang SC, Komo S, Bookheimer SY, et al. (2000). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA, 97, 6037–42.
  • Smith AJ, Faugére M-C, Abreo K, Fanti P, Julian B, Malluche HH. (1986). Aluminum-related bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity studies on etiology and diagnosis. Am J Nephrol, 6, 275–83.
  • Smith BS, Kothari H, Hayes BD. (2007). Effect of additive selection on calculated parenteral content of parenteral nutrient solutions. Am J Health Syst Pharm, 64, 730–9.
  • Sokolovska A, Hem SL, HogenEsch H. (2007). Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine, 25, 4575–85.
  • Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A. (2011). Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother, 11, 677–708.
  • Sood PK, Nahar U, Nehru B. (2011). Curcumin attenuates aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain. Neurotox Res, 20, 351–61.
  • Sood PK, Nahar U, Nehru B. (2012). Stress proteins and glial cell functions during chronic aluminum exposures: Protective role of curcumin. Neurochem Res, 37, 639–46.
  • Sorenson JR, Campbell IR, Tepper LB, Lingg RD. (1974). Aluminum in the environment and human health. Environ Health Perspect, 8, 3–95.
  • Stadler T, Buteler M, Weaver DK. (2010). Novel use of nanostructured alumina as an insecticide. Pest Manag Sci, 66, 577–9.
  • Stahl T, Taschan H, Brunn H. (2011). Aluminium content of selected foods and food products. Environ Sci Eur, 23, 37–48.
  • Steinhagen WH, Cavender FL, Cockrell BY. (1978). Six month inhalation exposures of rats and guinea pigs to aluminum chlorhydrate. J Environ Pathol Toxicol, 1, 267–77.
  • Stevanović ID, Jovanovic MD, Colic M, Jelenkovic A, Bokonjic D, Ninkovic M, Stojanovic I. (2011). N-nitro-L-arginine methyl ester influence on aluminium toxicity in the brain. Folia Neuropathol, 49, 219–29.
  • Streker M, Reuther T, Verst S, Kerscher M. (2010). Hyperhidrosis axillaries – Effektivitat und Vertraglichkeit eines aluminiumchloridhaltigen Antiperspirants; Prospective Evaluation on 20 Patienten mit idiopathischer Hyperhidrosis axillaries. Hautartz, 61, 139–44.
  • Strozyk D, Launer LJ, Adlard PA, Cherny RA, Tsatsanis A, Volitakis I, et al. (2009). Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid. Neurobiol Aging, 30, 1069–77.
  • Sumathi T, Shobana C, Kumari BR, Nandhini DN. (2011). Protective effect of Cynodon dactylon in ameliorating the aluminium-induced neurotoxicity in rat brain regions. Biol Trace Elem Res, 144, 843–53.
  • Sun H, Hu C, Jia L, Zhu Y, Zhao H, Shao B, et al. (2011b). Effects of aluminum exposure on serum sex hormones and androgen receptor expression in male rats. Biol Trace Elem Res, 144, 1050–8.
  • Sun J, Wang S, Zhao D, Hun FH, Weng L, Liu H. (2011a). Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol Toxicol, 27, 333–42.
  • Sun Z-Z, Chen Z-B, Jiang H, Li L-L, Li E-G, Xu Y. (2009). Alteration of Aβ metabolism-related molecules in predementia by AlCl3 and D-galactose. Age (Dordr), 31, 277–84.
  • Swaile DF, Elstun LT, Benzing KW. (2012). Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists. Br J Dermatol, 166, 22–6.
  • Taiwo OA. (2014). Diffuse parenchymal diseases associated with aluninum use and primary aluminum production. J Occup Environ Med, 56(5S), S18–22.
  • Tariba B. (2011). Metals in wine-impact on wine quality and health outcomes. Biol Trace Elem Res, 144, 143–56.
  • Theeten H, Van DP, Hoppenbrouwers K, Vandermeulen C, Leback E, Sokal EM, et al. (2005). Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. Vaccine, 23, 1515–21.
  • Theng BK, Yuan G. (2008). Nanogeoscience: nanoparticles in the soil environment. Elements, 4, 395–9.
  • Theng BKG, Russell M, Churchman GJ, Parfitt RL. (1982). Surface properties of allophone, halloysite and imogolite. Clays Clay Miner, 30, 143–9.
  • Thinakaran G, Koo EH. (2008). Amyloid precursor protein trafficking, processing and function. J Biol Chem, 283, 29615–9.
  • Thirunavukkarasu SV, Upadhyay LU, Venkataraman S. (2011). Effect of aluminum induced toxicity on behavioral and hematological parameters under the influence of Manasamitra vatakam (an Ayurvedic formulation) in rats. PhOL, 1, 594–603.
  • Thirunavukkarasu SV, Venkataraman S, Lokesh U. (2010). Effect of aluminum chloride on testicular function under the influence of Manasamita vatakam an indigenous formulation. PhOL, 1, 236–42.
  • Thirunavukkarasu SV, Venkataraman S, Raja S, Upadhyay L. (2012). Neuroprotective effect of Manasamitra vatakam against aluminium induced cognitive impairment and oxidative damage in the cortex and hippocampus of rat brain. Drug Chem Toxicol, 35, 104–15.
  • Toda S, Yase Y. (1998). Effect of aluminum on iron-induced lipid peroxidation and protein oxidative modification of mouse brain homogenate. Biol Trace Elem Res, 61, 207–17.
  • Tomljenovic L. (2011). Aluminum and Alzheimer's disease: after a century of controversy is there a possible link? J Alzheimers Dis, 23, 567–98.
  • Tomljenovic L, Shaw CA. (2011a). Aluminum vaccine adjuvants: are they safe? Curr Med Chem, 18, 2630–7.
  • Tomljenovic L, Shaw CA. (2011b). Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem, 105, 1489–99.
  • Tomljenovic L, Shaw CA. (2012). Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. Lupus, 21, 223–30.
  • Touam M, Martinez F, Lacour B, Bourdon R, Zingraff J, Dicuilio S, Drueke T. (1983). Aluminum-induced, reversible microcytic anemia in chronic renal failure: Clinical and experimental studies. Clin Nephrol, 19, 295–8.
  • Tripathi S, Mahdi AA, Hasan M, Mitra K, Mahdi F. (2011). Protective potential of Bacopa monniera (Brahmi) on aluminum induced cerebellar toxicity and associated neuromuscular status in aged rats. Cell Mol Biol (Noisy-le-grand), 57, 3–15.
  • Tsaousi A, Jones E, Case CP. (2010). The in vitro genotoxicity of orthopaedic ceramic (Al2O3) and metal (CoCr alloy) particles. Mutat Res, 29, 1–9.
  • Tsunoda M, Sharma RP. (1999). Modulation of tumor necrosis factor alpha expression in mouse brain after exposure to aluminum in drinking water. Arch Toxicol, 73, 419–26.
  • Turconi G, Minoia C, Ronchi A, Roggi C. (2009). Dietary exposure estimates of twenty-one trace elements from a Total Diet Study carried out in Pavia, Northern Italy. Br J Nutr, 101, 1200–8.
  • Turkez H, Geyikoĝlu F. (2011). The efficacy of bismuth subnitrate against genotoxicity and oxidative stress induced by aluminum sulphate. Toxicol Ind Health, 27, 133–42.
  • Turkez H, Geyikoĝlu F, Tatar A. (2013). Borax counteracts genotoxicity of aluminum in rat liver. Toxicol Ind Health, 29, 775–9.
  • Turkez H, Yousef MI, Geyikoĝlu F. (2010). Propolis prevents aluminium-induced genetic and hepatic damages in rat liver. Food Chem Toxicol, 48, 2741–6.
  • United Kingdom Medicines and Healthcare Regulatory Agency. (2010a). Calcium gluconate injection in small-volume glass containers: new contraindications due to aluminium exposure risk. Drug Safety Update 4(1): A2. Available at: http://www.mhra.gov.uk/home/groups/pl-p/documents/publication/con090933.pdf [Accessed 11 April 2014].
  • United Kingdom Medicines and Healthcare Regulatory Agency. (2010b). Calcium gluconate 10% in 10 ml glass containers: risk of aluminium exposure. MHRA Public Assessment Report. September 6. Available at: http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con093936.pdf [Accessed 11 April 2014].
  • US DHHS (US Department of Health and Human Services). (1982). Antiperspirant drug products for over-the-counter human use; tentative final monograph (proposed rule). 21 CFR Part 350. Federal Register, 47, 36492–505.
  • US DHHS (US Department of Health and Human Services). (2003). Antiperspirant drug products for over-the-counter human use; final monograph. 21 CFR Parts 310, 350 and 369. Federal Register, 68, 34273–93.
  • US FDA (US Food and Drug Administration). (1998). Aluminum in large and small volume parenterals used in total parenteral nutrition: proposed rule. Federal Register, 63, 176–85.
  • US FDA (US Food and Drug Administration). (2003). Amendment of regulations on parenteral nutrition; delay of effective date. Federal Register, 68, 32979–81.
  • US FDA (US Food and Drug Administration). (2013). Title 21 Food and Drugs Chapter I – Food and Drug Administration Title 21 Vol. 4. Subchapter C-Drugs: General. Part 201 Labeling Subpart G. Sec. 201.323. Aluminum in large and small volume parenterals used in parenteral nutrition. (Federal Register 65: 4110 Jan 26 2000 as amended at Federal Register 67: 70691 and Federal Register 68: 32981 June 3 2003). Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRsearch [Accessed on 5 September 2013].
  • van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. (1995). Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet, 346, 1070–1.
  • van der Voet GB, de Wolff FA. (1986–87). Intestinal absorption of aluminum from antacids: A comparison between hydrotalcite and algeldrate. J Toxicol Clin Toxicol, 24, 545–53.
  • Verbeken G, Schoeters D, Verween G, De VD, Pascual B, De CP, Geukens K, et al. (2011). Potential release of aluminum and other metals by food- grade aluminum foil used for skin allograft cryo preservation. Cell Tissue Bank, 12, 241–6.
  • Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E. (2005). Aluminium assay and evaluation of the local reaction at several time points after intramuscular injection of aluminium containing vaccines in the Cynomolgus monkey. Vaccine, 23, 1359–67.
  • Verghese J, Castellano M, Holtzman DM. (2011). Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol, 10, 241–52.
  • Verma NK, Moore E, Blau W, Volkov Y, Babu PR. (2012). Cytotoxicity evaluation of nanoclays in human epithelial cell line A549 using high content screening and real-time impedance analysis. J Nanoparticle Res, 14, 1137.
  • Verstraeten SV, Golub MS, Keen CL, Oteiza PI. (1997b). Myelin is a preferential target of aluminum-mediated oxidative damage. Arch Biochem Biophys, 344, 289–94.
  • Verstraeten SV, Nogueira LV, Schreier S, Oteiza PL. (1997a). Effect of trivalent metal ions on phase separation and membrane lipid packing: role in lipid peroxidation. Arch Biochem Biophys, 338, 121–7.
  • Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, et al. (2008). Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine, 26, 6630–8.
  • Viezeliene D, Jansen E, Rodovicius H, Kasauskas A, Ivanov L. (2011). Protective effect of selenium on aluminium-induced oxidative stress in mouse liver in vivo. Environ Toxicol Pharmacol, 31, 302–6.
  • Viezeliene D, Rodovicius H, Ivanov L. (2012). Effect of selenium on aluminium-induced changes in the translation system in mouse liver in vivo. Trace Elem Electrolytes, 29, 78–82.
  • Vittori D, Pregi N, Pérez G, Garbossa G, Nesse A. (2005). The distinct erythropoietic functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietic receptor. Biochim Biophys Acta, 1743, 29–36.
  • Vota DM, Crisp RL, Nesse AB, Vittori DC. (2012). Oxidative stress due to aluminium exposure induces eryptosis which is prevented by erythropoietin. J Cell Biochem, 113, 1581–9.
  • Wada K. (1987). Minerals formed and mineral formation from volcanic ash by weathering. Chem Geol, 60, 17–28.
  • Wagner AJ, Bleckmann CA, Murdock RC, Schrand AM, Schlager JJ, Hussain RC. (2007). Cellular interaction of different forms of aluminum nanoparticles in rat alveolar macrophages. J Phys Chem B, 111, 7353–9.
  • Wagner L, Verma A, Meade BD, Reiter K, Narum DL, Brady RA, et al. (2012). Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant. Clin Vaccine Immunol, 19, 1465–73.
  • Wald N. (1993). Folic acid and the prevention of neural tube defects. Ann NY Acad Sci, 678, 112–29.
  • Wallace WE Jr, Vallyathan V, Keane MJ, Robinson V. (1985). In vitro biological toxicity of native and surface modified silica and kaolin. J Toxicol Environ Health, 16, 415–24.
  • Walton JR. (2004). A bright field/fluorescent stain for aluminum: its specificity, validation and staining characteristics. Biotech Histochem, 79, 169–76.
  • Walton JR. (2010). Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease. J Alzheimers Dis, 22, 65–72.
  • Walton JR. (2012a). Cognitive deterioration and associated pathology induced by chronic low level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis, 2012, 914947.
  • Walton JR. (2012b). Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease. J Alzheimers Dis, 29, 255–73.
  • Wang, B, Xing W, Zhao Y, Deng X. (2010a). Effects of chronic aluminum exposure on memory through multiple signal transduction pathways. Environ Toxicol Pharmacol, 29, 308–13.
  • Wang N, She Y, Zhu Y, Zhao H, Shao B, Sun H, et al. (2012a). Effects of subchronic aluminum exposure on the reproductive function in female rats. Biol Trace Elem Res, 145, 382–7.
  • Watson LC, Gies D, Thompson E, Thomas B. (2012). Randomized control trial: evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of Stage 0, I, and II breast cancer. Int J Radiat Oncol, 83, e29–34.
  • Waxweiler RJ, Zumwalde RD, Ness GO, Brown DP. (1988). A retrospective cohort mortality study of males mining and milling attapulgite clay. Am J Ind Med, 13, 305–15.
  • Weberg R, Berstad A. (1986). Gastrointestinal absorption of aluminum from single doses of aluminum containing antacids in man. Eur J Clin Invest, 16, 428–32.
  • Wei SH, ChaoYN, Huang SE, Lee TF, Chang LY. (2011). Adverse effects of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in 6- to 7-year-old children. Pediatr Neonatol, 52, 38–41.
  • Weinbruch S, Benker N, Koch W, Ebert M, Drablos PA, Skaugset NP, et al. (2010). Hygroscopic properties of the workroom aerosol in aluminium smelter potrooms: a case for transport of HF and SO2 into the lower airways. J Environ Monit, 12, 448–54.
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. (2003). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.htm [Accessed 19 March 2013].
  • Westberg HB, Seldén AI, Bellander T. (2001). Exposure to chemical agents in Swedish aluminum foundries and aluminum remelting plants – a comprehensive survey. Appl Occup Environ Hyg, 16, 66–77.
  • WHO (World Health Organization). (1984). Guidelines for Drinking Water Quality. Vol 1, Recommendations. Lyon: World Health Organization. pp. 80.
  • WHO (World Health Organization). (2004). Guidelines for Drinking Water Quality, 3rd edition. Vol 1, Recommendations. Geneva: World Health Organization.
  • WHO (World Health Organization). (2010). Aluminium in Drinking Water. Background Document for Development of WHO Guidelines for Drinking-Water Quality. WH,O/HSE/WSH/10.01/13. Geneva: World Health Organization. pp. 1–15.
  • Wharton SB, Brayne C, Savva GM, Matthews FE, Forster G, Simpson J, et al. (2011). Epidemiological neuropathy: the MRC cognition function and aging study experience. J Alzheimers Dis, 25, 359–72.
  • Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, et al. (1995). A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q J Med, 88, 763–6.
  • Wier HA, Kuhn RJ. (2012). Aluminum toxicity in neonatal parenteral nutrition: what can we do? Ann Pharmacother, 46, 137–40.
  • Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M. (2011). Safety of pandemic H1N1 vaccines in children and adolescents. Vaccine, 29, 7559–71.
  • Wiles M, Huebner H, Afriyie-Gyawu E, Taylor R, Bratton G, Phillips T. (2004). Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet. J Toxicol Environ Health A, 67, 863–74.
  • Wilhelm M, Ghosh JK, Su J, Cockburn M, Jerret M, Ritz B. (2012). Traffic-related air toxics and term low birth weight in Los Angeles County, California. Environ Health Perspect, 120, 132–8.
  • Willhite CC, Ball GL, McLellan CJ. (2012). Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Crit Rev Toxicol, 42, 358–442.
  • Wilson JW. (1953). Nutritional deficiency produced in the mouse by feeding bentonite. J Natl Cancer Inst, 14, 57–63.
  • Wilson JW. (1954). Hepatomas produced in mice by feeding bentonite in the diet. Ann N Y Acad Sci, 57, 678–86.
  • Wisniewski HM. (1997). The role of aluminium in Alzheimer's disease. In: Priest ND, O’Donnell TV, eds. Managing Health in the Aluminium Industry. London: Middlesex University Press. pp. 263–73. Available at: http://www.world-aluminium.org/cache/f0000116.pdf [Accessed 10 June 2013].
  • Wisniewski HM, Wen GY. (1992). Review aluminum and Alzheimer's disease. Ciba Found Symp, 169, 142–54.
  • Wong WW, Chung SW, Kwong KP, Yin, HY, Xiao Y. (2010). Dietary exposure to aluminium of the Hong Kong population. Food Addit Contam A, 27, 457–63.
  • Wood SJ, Maleff B, Hart T, Wetzel R. (1996). Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol, 256, 870–7.
  • Wu Z, Du Y, Xue H, Wu Y, Zhou B. (2012a). Aluminum induces neurodegeneration and its toxicity arises from increased iron accumulation and reactive oxygen species (ROS) production. Neurobiol Aging, 33, 199.e1–12.
  • Wu X, Li J, Hu JN, Deng ZY. (2012b). The effects of glutamate and citrate on absorption and distribution of aluminum in rats. Biol Trace ElemRes, 148, 83–90.
  • Wu MJ, Murphy PA, O’Doherty PJ, Mieruszynski S, Jones M, Kersaitis C, et al. (2012c). Delineation of the molecular mechanism for disulfide stress-induced aluminium toxicity. Biometals, 25, 553–61.
  • Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, et al. (2012d). Early-onset familiar Alzheimer's disease (EOFAD). Can J Neurol Sci, 39, 436–45.
  • Xiao F, Li XG, Zhang XY, Hou JD, Lin LF, Gao Q, Luo HM. (2011). Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain. Neurosci Bull, 27, 143–55.
  • Xie CX, Yokel RA. (1996). Aluminum facilitation of iron-mediated lipid peroxidation is dependent on substrate, pH and aluminum and iron concentrations. Arch Biochem Biophys, 327, 222–6.
  • Yanagishita T, Tamada Y, Ohshima Y, Ito K, Akita Y, Watanabe D. (2012). Histological localization of aluminum in topical aluminum chloride treatment for palmar hyperhidrosis. J Dermatol Sci, 67, 69–71.
  • Yang X, Bi S, Yang L, Zhu Y, Wang X. (2003). Multi-NMR and fluorescencespectra study the effects of aluminium (III) on coenzyme NADH in aqueous solutions. Spectrochim Acta A Mol Biomol Spectrosc, 59, 2561–9.
  • Yang X, Cai L, Peng Y, Li H, Chen RF, Shen RF. (2011). Effects of Al(III) and nano-Al(13) species on malate dehydrogenase activity. Sensors (Basel), 11, 5740–53.
  • Yang X, Zhang Q, Li L, Shen R. (2007). Structural features of aluminium (III) complexes with bioligands in glutamate dehydrogenase reaction system – a review. J Inorg Biochem, 101, 1242–50.
  • Yates CM, Butterworth J, Tennant MC, Gordon A. (1990). Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem, 55, 1624–30.
  • Yin da P, Zhu BP, Wang HQ, Cao L, Wu WD, Jiang KY, et al. (2011). Effect of aluminum hydroxide adjuvant on the immunogenicity of the 2009 pandemic influenza A/H1N1 vaccine: multi-level modeling of data with repeated measures. Biomed Environ Sci, 24, 624–9.
  • Yiu G. (2004). Rapid communications: Antiperspirant induced DNA damage in canine cells by Comet assay. Toxicol Mech Methods, 15, 25–8.
  • Yokel RA. (1989). Aluminum produces age related behavioral toxicity in the rabbit. Neurotoxicol Teratol, 11, 237–42.
  • Yokel RA. (2000). The toxicology of aluminum in the brain: a review. Neurotoxicology, 21, 813–28.
  • Yokel RA. (2002). Brain uptake, retention and efflux of aluminum and manganese. Environ Health Perspect, 110, 699–704.
  • Yokel RA. (2012). Aluminum in food – the nature and contribution of food additives. In: El-Samragy Y, ed. Food Additives. ISBN 978-953-51-0067-6, In Tech 203-228. Available at: http://www.intechopen.com/articles/show/title/aluminum-in-food-the-nature-and-contribution of-food-additives [Accessed 26 August 2013].
  • Yokel RA. (2013). Aluminum. In: Cabello A, ed. Encyclopedia of Human Nutrition, 3rd edition. Vol 1. Waltham, MA: Academic Press. pp. 57–63.
  • Yokel RA, Florence RL (2006). Aluminium bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. Toxicology, 227, 86–93.
  • Yokel RA, Florence RL. (2008). Aluminum bioavailability from tea infusion. Food Chem Toxicol, 46, 3659–63.
  • Yokel RA, Hicks CL, Florence RL. (2008)Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent incorporated into cheese. Food Chem Toxicol, 46, 2261–6.
  • Yokel RA, MacPhail RC. (2011). Engineered nanomaterials: exposures, hazards and risk prevention. J Occup Med Toxicol 6: 7. Available at: http://www.occup-med.com/content/6/1/7 [Accessed 10 June 2013].
  • Yokel RA, McNamara PJ. (1985). Aluminum bioavailability and disposition in adult and immature rabbits. Toxicol Appl Pharmacol, 77, 344–52.
  • Yokel RA, McNamara PJ. (2001). Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol, 88, 159–67.
  • Yokel RA, Rhineheimer SS, Brauer RD, Sharma P, Elmore D, McNamara PJ. (2001). Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardness. Toxicology, 161, 93–101.
  • Yoon PW, Jang WY, Yoo JJ, Yoon KS, Kim HJ. (2011). Malignant fibrous histiocytoma at the site of an alumina-on-alumina-bearing total hip arthroplasty mimicking infected trochanteric bursitis. J Arthroplasty, 27, 324e9–12.
  • Yoshida S, Gershwin ME, Keen CL, Donald JM, Golub MS. (1989). The influence of aluminum on resistance to Listeria monocytogenes in Swiss-Webster mice. Int Arch Allergy Appl Immunol, 89, 404–9.
  • Yousef MI. (2004). Aluminum-induced changes in hemato-biochemical parameters, lipid peroxidation and enzymes of male rabbits: protective role of ascorbic acid. Toxicology, 199, 47–57.
  • Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. (2013). Prepregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PloS One, 8, e61627.
  • Yu HY, Zhang KL. (2011). Links between environmental geochemistry and rate of birth defects: Shanxi Province, China. Sci Total Environ, 409, 447–51.
  • Yu SL, Shi WX, Lu Y, Yang JX. (2011). Characterization and anti-fouling performance of nano-Al2O3/PVDF membrane for Songhua river raw water filtration. Water Sci Technol, 64, 1892–7.
  • Yuan C-Y, Lee Y-J, Wang Hsu G-S. (2012). Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J Biomed Sci, 19, 51.
  • Yue CS, Christie M, Lavergne V, Sikaneta T, Taskapan H, Mardini K, et al. (2011). Aluminum toxicokinetics in peritoneal dialysis patients. Clin Toxicol (Phila), 49, 659–63.
  • Yumoto S, Kakimi S, Ohsaki A, Ishikawa A. (2009). Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J Inorg Biochem, 103, 1579–84.
  • Yumoto S, Nagai H, Kobayashi K, Tamate A, Kakimi S, Matsuzaki, H. (2003). 26Al incorporation into the brain of suckling rats through maternal milk. J Inorg Biochem, 97, 155–60.
  • Yumoto S, Nagai H, Matsuzaki H, Matsumara H, Tada W, Nagatsuma E, Kobayashi K. (2001). Aluminum incorporation into the brain of rat fetuses and sucklings. Brain Res Bull, 15, 229–34.
  • Zagorski MG, Barrow CJ. (1992). NMR studies of amyloid beta peptides: proton assignments, secondary structure and mechanism of an alpha-helix-beta-sheet conversion for a homologous 28 residue N-terminal fragment. Biochemistry, 31, 5621–31.
  • Zatta P, Kiss T, Suwalsky M, Berthon G. (2002). Aluminium (III) as a promoter of cellular oxidation. Coord Chem Rev, 228, 271–84.
  • Zeager M, Woolf AD, Goldman RH. (2012). Wide variation in reference values for aluminum levels in children. Pediatrics, 129, e142–7.
  • Zeng KW, Fu H, Liu GX, Wang XM. (2011). Aluminum maltolate induces primary rat astrocyte apoptosis via overactivation of the class III PI3K/Beclin 1-dependent autophagy signal. Toxicol In Vitro 26, 215–20.
  • Zhang L, Li X, Gu Q, Zhu Y, Zhao H, Li Y, Zhang Z. (2011a). Effects of subchronic aluminum exposure on serum concentrations of iron and iron- associated proteins in rats. Biol Trace Elem Res, 141, 246–53.
  • Zhang QL, Jia L, Jiao X, Guo WL, Ji JW, Yang HL, Niu Q. (2012). APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model. Int J Immunopathol Pharmacol, 25, 49–58.
  • Zhang QL, Li MQ, Ji JW, Gao FP, Bai R, Chen CY, et al. (2011b). In vivo toxicity of nano-alumina on mice neurobehavioral profiles and the potential mechanisms. Int J Immunopathol Pharmacol, 24, S23–9.
  • Zhang QL, Niu Q, Niu PY, Ji XL, Zhang C, Wang, L. (2010a). Novel interventions targeting on apoptosis and necrosis induced by aluminum chloride in neuroblastoma cells. J Biol Regul Homeost Agents, 24, 137–48.
  • Zhang QL, Niu Q, Niu PY, Shi YT, Liu CY, Di GM, et al. (2010b). Bax gene silencing: a potential intervention in aluminum-induced neural cell death. J Biol Regul Homeost Agents, 24, 7–17.
  • Zhang XQ, Yin LH, Tang M, Pu YP. (2011c). ZnO, TiO2, SiO2, and Al2O3 nanoparticles- induced toxic effects on human fetal lung fibroblasts. Biomed Environ Sci, 24, 661–9.
  • Zhao J, Castranova V. (2011). Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B, 14, 593–632.
  • Zhu Y, Han Y, Zhao H, Li J, Hu C, Li Y, Zhang Z. (2013). Suppressive effect of accumulated aluminum trichloride on the hepatic microsomal cytochrome P450 enzyme system in rats. Food Chem Toxicol, 51, 210–14.
  • Zhu Y, Hu C, Li X, Shao B, Sun H, Zhao H, Li Y. (2012a). Suppressive effects of aluminum trichloride on the T lymphocyte immune function of rats. Food Chem Toxicol, 50, 532–5.
  • Zhu Y, Li X, Chen C, Wang F, Li J, Hu C, et al. (2012b). Effects of aluminum trichloride on the trace elements and cytokines in the spleen of rats. Food Chem Toxicol, 50, 2911–5.
  • Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. (2009). A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med, 361, 2414–23.
  • Zhu Y, Xu J, Sun H, Hu C, Zhao H, Shao B, et al. (2011a). Effects of aluminum exposure on the allergic responses and humoral immune function in rats. Biometals, 24, 973–7.
  • Zhu Y, Zhao H, Li X, Zhang L, Hu C, Shao B, et al. (2011b). Effects of subchronic aluminum exposure on the immune function of erythrocytes in rats. Biol Trace Elem Res, 143, 1576–80.
  • Zuo R, Ornek D, Wood TK. (2005). Aluminum- and mild steel- binding peptides from phage display. Appl Microbiol Biotechnol, 68, 505–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.